Top Specialists for International Patients

The BenQ Medical Group has over 1000 full-time doctors, including 35 senior experts from Taiwan and overseas, as well as 344 chief/deputy chief physicians, providing reliable diagnosis and treatment services for international patients.

Listed below are the senior experts from various departments of BENQ. Find the expert corresponding to your symptoms, click on the photo to view their detailed profile. You may wonder that this expert is from Shanghai, not from BENQ Hospital. Yes, you read it correctly, doctors in China can practice at multiple locations. Leveraging the strong resources and financial strength of a listed company, BENQ Medical Center has hired department heads and senior experts from top public hospitals in Shanghai, Suzhou, and Nanjing. All displayed experts are available for surgery appointments, genuine and effective, and can be found on the BENQ official website. (You can quickly find the corresponding department by clicking on the dropdown menu)

All surgeons available

Video consults available

30-Minute Consultation

Fees: $100–$300

Breast Surgery Department

Professor Fei Zhewei
Associate Chief Physician Wu Yanmei
Chief Physician Lin Xiaoyan

Scope of treatment

Thyroid: nodules, hyperthyroidism, hypothyroidism, inflammation, benign and malignant tumors, neck lymph node dissection, postoperative recurrence, parathyroid diseases.

Breast: hyperplasia, nodules, cysts, acute and chronic inflammation, benign and malignant tumors, breast cancer breast-conserving surgery/reconstruction, male breast development, nipple discharge, supernumerary breast tissue.

(1) Thyroid Surgery
Thyroid Radiofrequency Ablation (RFA) Minimally Invasive Treatment
Indications: Benign nodules, low-risk small cancers, postoperative recurrent lesions.
Features: Local anesthesia, needle puncture incision, 10-30 minutes, discharge on the same day/next day, no scar on the neck.
Scarless Endoscopic Thyroid Surgery
Approaches: Trans-axillary, periareolar, oral vestibule, submental.
Advantages: No scar on the neck, high-definition vision, strong protection of nerves and blood vessels, fast recovery.
Standardized Open Surgery
Radical treatment of thyroid benign and malignant tumors, near-total/total resection, central and lateral neck lymph node dissection.
Recurrent Laryngeal Nerve Protection Technique
Real-time monitoring with nerve monitoring device during surgery significantly reduces the risk of hoarseness.

(2) Breast Surgery
Breast Minimally Invasive Excisional Biopsy
Indications: Benign nodules, microcalcifications, suspicious lesion biopsy.
Features: 3mm incision, outpatient/day surgery, precise, scarless, rapid recovery.
Breast-Conserving Mastectomy
Xinhua “Small Knife Faction” fine style: clean margins, preserved shape, minimally invasive axillary approach.
Breast Reconstruction
Immediate/two-stage implantation, autologous flaps (DIEP, TRAM) reconstruction.
Endoscopic Breast Surgery
Approaches through axilla/nipple: male breast reduction, breast conservation, implantation, scarless on the body surface.
Refractory Breast Abscess Radiofrequency Ablation
For granulomatous mastitis: minimally invasive, breast conservation, reduced recurrence, avoiding incision and drainage.

Giant breast cancer rupture shock treatment (72-year-old female)
Tumor >10cm, ruptured bleeding shock, emergency MDT assessment, palliative radical treatment + wound repair, comprehensive postoperative treatment, long-term survival, good quality of life.

Thyroid microcarcinoma radiofrequency ablation (38-year-old female)
6mm low-risk papillary carcinoma, refused surgery, underwent ultrasound-guided ablation, 20 minutes, local anesthesia, discharged on the same day, follow-up showed no recurrence, normal thyroid function, no scar on the neck.

Plasma cell mastitis (35-year-old female)
Repeated redness, swelling, and rupture, ineffective medication, underwent breast radiofrequency ablation, minimally invasive breast-conserving, recovered in 1 week, no recurrence.

Endoscopic thyroid cancer radical treatment (28-year-old female)
Thyroid cancer + lymph node metastasis, underwent axillary endoscopic radical treatment, no scar on the neck, normal voice, discharged 3 days after surgery.

Early-stage breast cancer breast-conserving reconstruction (45-year-old female)
1.2cm invasive cancer, underwent breast-conserving radical treatment + tumor shaping, symmetrical appearance, natural look, 5-year disease-free survival.

Metabolic Weight Loss Surgery

Professor Li Weijie (Dean)
Professor Mao Zhongqi (Executive Director)

Scope of treatment

Obesity: simple obesity, pathological obesity, severe obesity.

Metabolic diseases: type 2 diabetes, hypertension, hyperlipidemia, fatty liver, sleep apnea, polycystic ovary syndrome, hyperuricemia.

Laparoscopic one-anastomosis gastric bypass (OAGB)【Core Features】
Principle: Reduce stomach capacity + alter intestinal pathway, effectively promote weight loss + lower blood sugar.
Advantages: Leading nationwide, reduced surgical difficulty, excellent weight loss and blood sugar reduction effects, fewer postoperative complications.
Indications: Severe obesity (BMI≥35), type 2 diabetes, metabolic syndrome.

Laparoscopic sleeve gastrectomy (SG)
Principle: Remove most of the stomach, forming a sleeve-shaped small stomach, reducing hunger hormone.
Advantages: Minimally invasive, simple operation, quick recovery, clear weight loss effects.
Indications: Simple obesity, moderate obesity, obesity combined with hypertension/fatty liver.

Laparoscopic Roux-en-Y gastric bypass (RYGB)
Principle: Classic weight loss and blood sugar reduction procedure, small gastric pouch + intestinal bypass, long-lasting effects.
Indications: Super obesity, severe type 2 diabetes, combined with various metabolic diseases.

Single anastomosis double loop surgery (SASI)
Principle: Innovative procedure combining intake restriction and absorption reduction, outstanding blood sugar reduction effects.
Indications: Secondary repair for poor outcomes, weight regain, and complications after previous weight loss surgeries.

Internal medicine comprehensive treatment
Diet intervention, exercise guidance, drug therapy, lifestyle reshaping, preferred for non-surgical patients.

A super obese patient (male, 28 years old)
Preoperative: BMI 63.2, severe obesity, sleep apnea, fatty liver, insulin resistance.
Procedure: Laparoscopic OAGB.
Outcome: Smooth surgery, got out of bed on the first day after surgery, discharged on the third day, continuous weight loss, comprehensive improvement in metabolic indicators.


A patient with polycystic ovary syndrome and obesity (female, 25 years old)
Preoperative: Weight 120.5kg, BMI 49.5, hypertension, fatty liver, amenorrhea.
Procedure: OAGB.
Outcome: Weight loss of 93 斤 after 1 year of surgery, menstruation returned to normal, successfully married.


A patient with diabetes and obesity (male, 40 years old)
Preoperative: Weight 156kg, BMI 51.8, diabetes, hypertension, hyperlipidemia, severe sleep apnea.
Procedure: Gastric bypass surgery.
Outcome: Weight loss of 61.6kg after 9 months of surgery, diabetes and hypertension cured and stopped medication.

Cardiovascu larInternal Medicine

Xu Weiting (Director of Cardiology)
Shi Cheng (Deputy Director of Cardiology)

Scope of treatment

Heart disease: angina pectoris, myocardial infarction, stent restenosis, coronary artery spasm, complex multivessel disease.

Arrhythmia: atrial fibrillation, supraventricular tachycardia, ventricular tachycardia, premature beats, bradycardia, atrioventricular block.
Valvular disease: mitral valve / aortic valve / tricuspid regurgitation / stenosis, infective endocarditis.
Heart failure: acute and chronic heart failure, dilated cardiomyopathy, hypertrophic cardiomyopathy.

Hypertension: primary / secondary hypertension, resistant hypertension.

Congenital heart disease: atrial septal defect, ventricular septal defect, patent ductus arteriosus, Tetralogy of Fallot, etc.

Others: aortic dissection, pulmonary hypertension, pericardial disease, myocarditis, etc. 

(1) Coronary Heart Disease and Chest Pain Center
Complex Coronary Intervention: Conduct IVUS/OCT assessment, calcified plaque rotational atherectomy, and other high-risk procedures, with over 800 cases completed annually, capable of managing difficult cases such as left main coronary artery and CTO occlusions.
Coronary Artery Bypass Surgery: Collaboration between internal and cardiovascular surgery, providing one-stop solutions for complex multivessel lesions with grafting and stent placement.
Chest Pain Green Channel: Achieving a high success rate in treating acute myocardial infarction with a door-to-balloon time ≤60 minutes.

(2) Arrhythmia and Electrophysiology Center
Comprehensive Atrial Fibrillation Treatment: One-stop surgery combining radiofrequency ablation and left atrial appendage closure, including thoracoscopic hybrid treatments.
Zero-Fluoroscopy Electrophysiology: Three-dimensional ablation guided by ICE, suitable for sensitive populations such as pregnant women and children.
Physiological Pacing: Performing LBBP/HBP procedures, implanting devices like ICDs and CRTs to manage challenging arrhythmias.

(3) Valvular Heart Disease and Structural Heart Disease
TEER Minimally Invasive Valve Repair: Mitral valve repair via catheterization without open-heart surgery, suitable for elderly high-risk patients.
– Minimally Invasive Valve Replacement/Repair, performing left atrial appendage closure as an alternative to long-term anticoagulation.

(4) Heart Failure and Hypertension
Comprehensive Heart Failure Management: Integrating medication, devices, and rehabilitation; renal artery denervation for refractory hypertension.

(5) Congenital Heart Disease
Performing minimally invasive interventions for atrial and ventricular septal defects closure, as well as complex congenital cardiac surgeries for children and adults.

Left main coronary artery lesion acute myocardial infarction emergency rescue
The patient suddenly experienced chest pain and syncope. Angiography showed 90% stenosis of the left main coronary artery + occlusion of the left anterior descending branch. The chest pain green channel was opened centrally, a stent was implanted to open the blood vessel in 15 minutes, the heart rate recovered, and the patient’s condition stabilized.

Severe mitral valve regurgitation transcatheter edge-to-edge repair (TEER)
A 67-year-old patient with severe mitral valve regurgitation and poor heart function unable to tolerate open-heart surgery. TEER minimally invasive repair was performed with a 5mm incision in the femoral vein, completed in 2 hours. The patient got out of bed the day after the surgery, recovered within a week, and experienced significant relief of chest tightness and shortness of breath symptoms.

Pregnant patient zero-fluoroscopy supraventricular tachycardia ablation
A 17-week pregnant woman experiencing frequent episodes of supraventricular tachycardia with a heart rate of 180 beats per minute. Zero-fluoroscopy ablation guided by intracardiac ultrasound was performed to protect the mother and fetus from radiation. The surgery was successful, and the patient gave birth smoothly.

Neurology Department

Yuan Qingfang (Director, Ph.D., Chief Physician)
Xue Shouru (Ph.D., Chief Physician, Professor)
Ye Min (Professor, Parkinson's Disease/Movement Disorders Specialist)
Zhang Zengping (Associate Chief Physician)

Scope of treatment

Scope of treatment:Cerebrovascular diseases: cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, cerebral artery dissection, carotid artery / intracranial artery stenosis, cerebral aneurysm, vascular malformation.
Movement disorders: Parkinson’s disease, Parkinson’s syndrome, essential tremor, dystonia, myotonia.
Epilepsy: various types of epilepsy (primary, secondary, refractory), status epilepticus.
Neuroimmune diseases: multiple sclerosis, neuromyelitis optica, myasthenia gravis, Guillain-Barré syndrome, autoimmune encephalitis.
Headache and dizziness: migraine, tension-type headache, cluster headache, benign paroxysmal positional vertigo, vertebrobasilar insufficiency, vestibular neuritis.
Cognitive impairment: Alzheimer’s disease, vascular dementia, frontotemporal dementia.
Neurocritical care: non-traumatic coma, encephalitis, meningitis, myelitis.
Others: motor neuron disease, multiple system atrophy, sleep disorders, neuromuscular diseases.

(1) Stroke (Core Advantages)
– Ultra-early vascular recanalization: conducting venous thrombolysis, bridging mechanical thrombectomy (time window ≤ 24 hours), and controlling DNT within the standard range.
– Neurointervention: DSA angiography, intracranial and extracranial arterial stenting, intracranial arterial aneurysm coiling, and arterial dissection intervention.
– Stroke green channel: seamless connection with 120, triage assessment within 10 minutes, treating hundreds of cases annually; acute phase bedside rehabilitation intervention.
(2) Parkinson’s Disease and Movement Disorders
– Precision diagnosis: conducting IMR, olfactory testing, and DAT imaging in collaboration with Xiangya Hospital; standardized treatment, DBS surgery can be performed in the middle and late stages.
– Chronic disease management: establishing a patient database, providing long-term follow-up guidance, and delaying disease progression.
(3) Epilepsy and Neuroimmune Diseases
– Epilepsy diagnosis and treatment: relying on dynamic/long-term video EEG to locate lesions, collaborating with Sanbo Neurology for remote consultations, and providing a one-stop solution.
– Neuroimmune treatment: proficient in severe diseases such as multiple sclerosis, using immunomodulation, plasma exchange, and other strategies with a high success rate.
(4) Other Specialized Techniques
Conducting non-traumatic coma treatment, BPPV maneuver reduction, offering free consultation clinics for difficult diseases, and integrating multidisciplinary precision diagnosis and treatment.

1. Emergency treatment for acute cerebral infarction (arterial dissection)
A 28-year-old male presented with sudden weakness in the right limbs, slurred speech, and severe headache. Diagnosed with acute cerebral infarction due to arterial dissection. Stroke center on standby 24 hours, rapid DSA evaluation, followed by arterial thrombolysis + stent placement. Blood vessel opened in 90 minutes, with basic recovery of limb function after 1 week post-operation, discharged without sequelae.

2. Comprehensive treatment for mid-to-late stage Parkinson’s disease
A 72-year-old female with Parkinson’s disease for 5 years, presenting with dyskinesia, gait freezing, and other symptoms. Optimized medication regimen + rehabilitation training, concurrent psychological counseling and bowel management, followed by DBS surgery with parameter optimization. Symptoms significantly relieved 3 months post-operation, leading to a substantial improvement in quality of life.

3. Management of myasthenic crisis
A 45-year-old female developed sudden difficulty in breathing and swallowing, diagnosed with myasthenic crisis with respiratory failure. Transferred to the NICU for endotracheal intubation and ventilation, treated with immunoglobulins + plasma exchange. Discharged after 1 week off the ventilator, and 2 weeks later for long-term management with stable condition.

Thoracic Surgery

Liu Huiping (Chief Expert, Deputy Dean)
Wei Jingyi (Director, Chief Physician)
Liu Changjian (Chief Physician, Professor)
Chen Shilin (Chief Physician)

Scope of treatment

Lung diseases: lung cancer, pulmonary nodule, pulmonary bulla, emphysema, lung abscess, pulmonary sequestration, etc.
Esophageal diseases: esophageal cancer, benign esophageal tumor, cardia cancer, esophageal diverticulum, esophageal fistula, etc.
Mediastinal diseases: mediastinal tumor, thymoma, myasthenia gravis (thymectomy), mediastinal cyst, etc.
Chest wall diseases: pectus excavatum, pectus carinatum, chest wall tumor, rib fracture, etc.
Great vessel diseases: aortic dissection, thoracoabdominal aortic aneurysm, carotid artery stenosis, lower limb varicose veins, deep vein thrombosis, etc.
Chest trauma: pneumothorax, hemothorax, lung laceration, chest wall soft tissue injury, etc.

(1) Minimally Invasive Treatment for Chest Tumors (Core Advantages)
– Complete thoracoscopic radical treatment for lung cancer: single-port/multi-port lung lobe and segment resection, precise localization with fluorescence thoracoscopy navigation, minimally invasive lung protection, discharge 3-5 days post-surgery.
– Diagnosis and treatment of lung nodules: MDT one-stop management, performing CT-guided puncture localization, radiofrequency/microwave ablation, thoracoscopic nodule resection, precise intervention.
– Radical treatment for complex esophageal cancer: three-incision radical surgery, colon esophagus replacement, performing advanced difficult surgeries such as total thoracic vertebrectomy for late-stage lung cancer, achieving R0 resection.


(2) Diagnosis and Treatment of Major Vascular Diseases (Specialized Subspecialty)
– Minimally invasive repair of aortic diseases: performing TEVAR/EVAR minimally invasive stent implantation, suitable for elderly and high-risk patients, successfully repairing an 8cm thoracic aortic pseudoaneurysm.
– Treatment of carotid artery stenosis: performing endarterectomy, stent implantation to prevent stroke.


(3) Chest Trauma and Other Diseases
Performing internal fixation for rib fractures, repair of lung lacerations for chest trauma; thoracoscopic/mediastinoscopic resection of mediastinal tumors; Nuss procedure for minimally invasive correction of pectus excavatum, suitable for children and adults.

1. Precise minimally invasive treatment for pulmonary nodules
A 52-year-old female was found to have an 8mm pure ground-glass pulmonary nodule during a physical examination, causing concern for malignancy. After evaluation by the pulmonary nodule MDT team, she underwent CT-guided puncture localization + uniportal thoracoscopic segmental lung resection. Intraoperatively, a diagnosis of minimally invasive adenocarcinoma was confirmed, and the lesion was precisely resected. She was discharged 3 days postoperatively without the need for radiotherapy or chemotherapy, and follow-up showed no recurrence.

2. Minimally invasive repair of pseudoaneurysm of the thoracic aorta
A 36-year-old male with a history of Crohn’s disease presented with sudden chest tightness. CT revealed an 8cm pseudoaneurysm of the thoracic aorta with a high risk of rupture. A multidisciplinary team performed TEVAR minimally invasive stent implantation to isolate the aneurysm sac blood flow and avoid open chest surgery. Postoperatively, he recovered well, with follow-up showing disappearance of the aneurysm and patent blood vessels.

3. Secondary surgery for complex esophageal cancer
A 68-year-old male with recurrent anastomotic site esophageal cancer 5 years after initial surgery was deemed inoperable at another hospital. Under the direction of Director Wei Jingyi, a second radical surgery + colon esophageal replacement was performed to reconstruct the digestive tract. The surgery was successful, and he started a liquid diet 7 days postoperatively. One year of follow-up showed no recurrence, and he resumed a normal diet.

Otorhinolaryngology Head and Neck Surgery

Yu Zhenkun (Subject Leader, Dean)
Xia Yin (Head of ENT Department)
Lu Yuanyuan (Director of Otorhinolaryngology, Director of Snoring Center)
Gong Danchun (Executive Director, Deputy Director of Head and Neck Surgery)
Zhang Yijuan (Director of Rhinology)

Scope of treatment

otitis media, hearing loss, tinnitus, vertigo, facial paralysis, lateral skull base tumor, cochlear implantation.
Nose: sinusitis, nasal polyps, allergic rhinitis, deviated nasal septum, skull base tumor, nasolacrimal disorders.
Otorhinolaryngology: laryngeal papilloma, vocal cord polyps/nodules, early laryngeal cancer, snoring, pediatric adenoid hypertrophy, temporomandibular joint dislocation.
Head and Neck Surgery: thyroid/parathyroid tumors, laryngeal/pharyngeal cancer, nasal and sinus tumors, parotid/submandibular gland tumors, neck masses.

(1) Core Technologies in Otology
Carrying out cochlear implantation (pediatric/adult), radical mastoidectomy for chronic otitis media, reconstruction of ossicular chain; removal of skull base tumors while preserving nerve function; diagnosis and treatment of vertigo and facial paralysis, combined with vestibular rehabilitation; minimally invasive ear endoscopy surgery suitable for pediatric and elderly patients.

(2) Core Technologies in Rhinology
Minimally invasive endoscopic treatment for sinusitis, nasal polyps, etc., performing skull base tumor resection, repair of cerebrospinal fluid rhinorrhea; minimally invasive surgery for nasal and orbital diseases; standardized diagnosis and treatment of allergic rhinitis, including allergen testing and desensitization therapy.

(3) Core Technologies in Otolaryngology
CO₂ laser + photodynamic therapy for recurrent laryngeal papillomatosis; microlaryngeal surgery for voice disorders; minimally invasive excision of adenoids/tonsils (day surgery); temporomandibular joint relocation surgery (national patent), filling the regional gap.

(4) Core Technologies in Head and Neck Surgery
Minimally invasive/endoscopic thyroid surgery, refined resection of thyroid cancer; laser-assisted minimally invasive resection of early head and neck tumors, salvage treatment for advanced tumors; functional preservation surgery for laryngeal/hypopharyngeal cancer + voice reconstruction.

1. Cochlear implantation for hearing reconstruction
A 5-year-old prelingually deaf child with bilateral hearing loss of 90dB, unable to communicate normally. The otolaryngology team performed bilateral cochlear implantation surgery, followed by language rehabilitation training. After 3 months, the child could understand simple instructions, and after 1 year, could communicate fluently and smoothly integrate into kindergarten.

2. Salvage treatment for advanced head and neck tumor involving the carotid artery
A 70-year-old male with a huge neck tumor invading the carotid artery, deemed inoperable by an external hospital. The Zhongkun team, in collaboration with the interventional department, performed a hybrid surgery, implanting a carotid artery stent, followed by tumor resection and repair. The surgery was successful, with the patient surviving over 2 years and experiencing a significant improvement in quality of life.

3. Stereotactic treatment for laryngeal papillomatosis
A 3-year-old child with recurrent laryngeal papillomatosis for 5 years, experiencing multiple surgical relapses affecting breathing and voice. The otorhinolaryngology team utilized CO₂ laser + photodynamic therapy + medication for comprehensive treatment. After 1 year of follow-up, there was no recurrence, voice function returned to normal, and the need for long-term tracheostomy was avoided.

Urology

Wu Xuejie (Deputy Dean, Chief Physician, Ph.D.)
Shan Yuxi (Doctoral Supervisor, Renowned Physician)
Zhou Yun (Doctoral Supervisor, Chief Physician)

Scope of treatment

Urinary system stones: kidney stones, ureteral stones, bladder stones, urethral stones, stag horn stones, prevention of stone recurrence.
Prostate diseases: prostate enlargement, prostatitis, prostate cancer, urinary obstruction, urinary retention.
Urinary system tumors: kidney cancer, adrenal tumors, bladder cancer, prostate cancer, renal pelvis and ureter cancer.
Female urology: urinary incontinence, pelvic organ prolapse, interstitial cystitis, recurrent urinary tract infections.
Pediatric urology: congenital hydronephrosis, buried penis, cryptorchidism, hypospadias, urethral stricture, prenatal consultation for fetal urology.
Andrology diseases: varicocele, seminal vesiculitis, male infertility, sexual dysfunction.
Others: renal cysts, hydrocele, urethral stricture, adrenal hypertension, urological trauma.

(1) Minimally invasive system for the full chain of urinary stones
Comprehensive minimally invasive procedures without open surgery, 24-hour emergency lithotripsy; including extracorporeal shock wave lithotripsy (non-invasive outpatient), ureteroscopy with Olympus electronic flexible ureteroscope holmium laser lithotripsy (kidney-sparing non-invasive), percutaneous nephrolithotomy (for large stones); with stone composition analysis, recurrence prevention, and metabolic management.


(2) Fine-tuned minimally invasive spectrum for prostate diseases
Covering plasma vaporization/resection, Suzhou Dan Yuxi expert green light vaporization/resection (preferred for elderly anticoagulant therapy), holmium laser enucleation (HoLEP, international gold standard); leading in Nanjing, synchronously conducting Rezum thermal vapor ablation (suitable for very high-risk elderly); with urodynamic assessment and rehabilitation management.


(3) Minimally invasive radical cure integration for urological tumors
Laparoscopic radical nephrectomy/nephron-sparing surgery for renal cell carcinoma, adrenal tumors, bladder cancer, minimally invasive radical prostatectomy; exclusive Da Vinci robotic-assisted surgery in Nanjing (precision minimally invasive); MDT comprehensive closed-loop management (surgery + chemotherapy + immunotherapy + follow-up).


(4) Female urology and urinary control, pelvic floor diseases
Performing TOT/TVT minimally invasive suspension for urinary incontinence, pelvic organ prolapse repair, interstitial cystitis diagnosis and treatment, and pelvic floor rehabilitation.


(5) Correction of congenital abnormalities in pediatric urology
Performing UPJO correction, concealed penis correction, etc., Suzhou Zhou Yunbo specializes in prenatal consultation and postnatal treatment for fetal urological malformations.


(6) Andrology and other urological diseases
Treatment with vesiculoscopy, microsurgical varicocelectomy, diagnosis and treatment of male infertility/sexual dysfunction, as well as minimally invasive treatment for urethral strictures, renal cysts, etc.

Bladder cancer robot-assisted minimally invasive surgery at the age of 100
A 100-year-old patient with recurrent bladder cancer, complicated by hypertension, poor heart and lung function, and other underlying conditions, was deemed inoperable by another hospital. Following a multidisciplinary team (MDT) consultation led by Peng Guohui, the patient underwent a Da Vinci robot-assisted laparoscopic partial bladder resection, achieving precise tumor removal. The patient was able to get out of bed and eat on the first day after surgery, experienced no severe complications, recovered smoothly, and was discharged, with a focus on both tumor eradication and quality of life.

Super-aged 92-year-old with high-risk benign prostatic hyperplasia treated with steam vaporization
A 92-year-old patient with 5 years of urinary difficulty, a history of coronary artery bypass surgery, and long-term oral anticoagulant therapy, making them unsuitable for conventional surgery. Under the team led by Hong Bo, the patient underwent prostatic steam vaporization, which was completed in 5 minutes without bleeding or tissue removal. The patient experienced rapid urination postoperatively, did not need to discontinue anticoagulant therapy, and had no burden on heart and lung function, effectively resolving urinary retention and nocturia.

61-year-old with benign prostatic hyperplasia treated with steam vaporization to preserve function
A 61-year-old male with recurrent urinary retention and nocturia 4-5 times a night, concerned about potential surgical impact on sexual function. Minimally invasive treatment with steam vaporization was performed, taking 5 minutes to complete. Postoperatively, the patient had smooth urination, preserved sexual function, no retrograde ejaculation, and quickly returned to normal life.

Nephrology

Lou Jizhuang (Director of the Department, Chief Physician, Master Supervisor)
Gao Zhanhui (Deputy Director, Director of Hemodialysis Center, Chief Physician)
Ji Daxi (Specially Appointed Chief Expert)
Zhi Min (Director of the Department, Chief Physician)

Scope of treatment

Primary glomerular diseases: various types of nephritis, nephrotic syndrome, IgA nephropathy, membranous nephropathy, hematuria, proteinuria.
Secondary renal diseases: diabetic nephropathy, hypertensive nephropathy, gouty nephropathy, lupus nephritis, ANCA-associated vasculitis renal damage, purpura nephritis.
Acute and chronic renal failure: acute kidney injury, chronic kidney disease stages 1-5, uremia.
Blood purification related: maintenance hemodialysis, hemofiltration, perfusion, CRRT for critical care support, plasma exchange, peritoneal dialysis home management.
Dialysis vascular access: arteriovenous fistula, synthetic graft fistula, catheter insertion, fistula stenosis/occlusion intervention repair.
Uremia complications: secondary hyperparathyroidism, renal anemia, renal hypertension, renal osteodystrophy, electrolyte imbalance, pruritus.
Benign renal conditions: simple renal cysts, polycystic kidneys, urinary tract infections, interstitial nephritis, drug-induced renal injury.
Critical renal diseases: rhabdomyolysis renal injury, septic shock renal failure, uremic encephalopathy, heart failure renal failure combined treatment.

(1) Precision diagnostic techniques for kidney
Carrying out percutaneous renal biopsy guided by ultrasound (the gold standard for diagnosing kidney diseases, guiding individualized drug therapy); sclerotherapy for renal cyst puncture (completed in outpatient setting with low recurrence rate); comprehensive management of chronic kidney disease (CKD), establishing exclusive medical records, delaying kidney failure, and postponing dialysis.

(2) Full spectrum blood purification technology
Covering all mainstream purification modes: conventional hemodialysis (HD), hemodiafiltration (HDF), hemoperfusion (HP), continuous renal replacement therapy (CRRT, for critical care life support), double/regular plasma exchange (DFPP/PE), peritoneal dialysis (PD, suitable for elderly patients at home).

(3) MDT technology for dialysis vascular access
Performing autogenous arteriovenous fistula, prosthetic graft arteriovenous fistula, central venous catheter insertion; supporting interventional repair under DSA/ultrasound guidance, including fistula stenosis dilation, thrombus clearance, aneurysm repair, solving various difficult access problems.

(4) Precision treatment for secondary kidney diseases and uremia complications
Suzhou pioneered the targeted therapy of membranous nephropathy with rituximab; Nanjing General Hospital carried out microwave ablation of parathyroid glands (curing secondary hyperparathyroidism); integrated management of renal anemia, hypertension, and other complications, individualized treatment for various secondary kidney diseases.

(5) Emergency treatment of critical kidney diseases
Treating acute kidney injury, severe infection-related kidney failure, and other critical kidney diseases, using CRRT combined with multidisciplinary emergency care to reverse kidney function and discontinue dialysis.

Rare thrombotic microangiopathy, dual plasma exchange reverses renal failure
Elderly patient, pulmonary infection induced hemolytic uremic syndrome (thrombotic microangiopathy), complicated by acute renal failure, respiratory failure, requiring urgent dialysis and plasma shortage, poor prognosis at the previous hospital. Dr. Zhimin’s team initiated dual plasma exchange (DFPP), combined with immunosuppression, respiratory support, and infection control, successfully treated in a general ward. Postoperatively, renal function recovered, successfully weaned off dialysis, normal respiratory and coagulation function, stable follow-up, hospital simultaneously applied for public assistance to reduce the burden.

90-year-old elderly with difficult arteriovenous fistula occlusion intervention
90-year-old with long-term dialysis for uremia, existing arteriovenous fistula completely occluded, poor vascular conditions, multiple comorbidities, unable to create a new fistula. Dr. Zhanhui’s team performed drug-coated balloon intervention to dilate and open the fistula under DSA guidance, minimally invasive without surgery. Postoperatively, the fistula was unobstructed, resumed regular dialysis without the need for long-term indwelling catheters, avoiding infection risks, and the patient tolerated the procedure safely.

Refractory secondary hyperparathyroidism in uremia, microwave ablation for minimally invasive cure
Patient on dialysis for 8 years, severe secondary hyperparathyroidism, extremely high PTH levels, accompanied by systemic bone pain, skin itching, and other symptoms, ineffective drug treatment. Ultrasound-guided parathyroid microwave thermal ablation, local anesthesia, minimally invasive, needle puncture incision. Postoperatively, PTH rapidly decreased to normal levels, all symptoms relieved, vascular calcification stopped, improved nutrition and sleep, avoiding surgical resection trauma.

Liver, gallbladder, and pancreatic diseases

Chen Jianfeng (Center Director, Chief Physician)
Wu Haorong (Chief Physician, Professor, PhD Supervisor)
Wu Guoqiang (Chief Physician, Medical Doctor)

Scope of treatment

1. Liver diseases
Primary liver cancer, hepatic hemangioma, hepatic cyst, liver abscess, intrahepatic bile duct stones, cirrhosis, portal hypertension, splenomegaly, esophageal variceal bleeding, liver trauma.
2. Biliary tract diseases
Gallstones, gallbladder polyps, cholecystitis, common bile duct stones, biliary stricture, iatrogenic biliary injury, bile duct cancer, obstructive jaundice, congenital biliary malformation.
3. Pancreatic diseases
Pancreatic head cancer, pancreatic body and tail tumors, pancreatic neuroendocrine tumors, acute severe pancreatitis, pseudocysts of the pancreas, pancreatic duct stones, periampullary cancer.
4. Splenic diseases
Splenomegaly, splenic hyperfunction, splenic tumors, splenic diseases related to portal hypertension.
5. Interventional and endoscopic procedures for all diseases
Endoscopic stone removal for gallbladder and pancreas stones, biliary stent placement for jaundice reduction, transarterial chemoembolization (TACE) for liver cancer, tumor ablation, portal vein tumor thrombosis intervention, endoscopic ultrasound (EUS) diagnostic puncture.

(1) Precision minimally invasive diagnosis and treatment of liver diseases
Laparoscopic precision liver resection: anatomical resection, precise vascular protection, minimal bleeding with minimally invasive approach.
Stratified diagnosis and treatment of liver cancer: early-stage laparoscopic radical treatment, middle-late stage TACE + targeted immunotherapy, comprehensive follow-up throughout the process.
Minimally invasive treatment of liver cysts: ultrasound-guided puncture, laparoscopic fenestration, completed in outpatient/day surgery.
Minimally invasive treatment of portal hypertension: laparoscopic splenectomy + vascular ligation to prevent upper gastrointestinal bleeding.

(2) Comprehensive minimally invasive techniques for biliary diseases
Laparoscopic cholecystectomy: multi-port/single-port scarless, routinely performed as day surgery.
Dual endoscopy: common bile duct stone extraction, primary closure without T-tube, rapid recovery.
Non-invasive ERCP: oral route access, management of biliary and pancreatic stones, obstructions suitable for elderly patients.
Biliary tract repair: reshaping, choledochoenterostomy, management of postoperative complications.

(3) Minimally invasive diagnosis and treatment of pancreatic diseases
Radical treatment of pancreatic body and tail tumors: minimally invasive spleen preservation, retention of pancreatic function.
Excision of benign pancreatic tumors: precise resection, preservation of pancreatic function.
Diagnosis and treatment of pancreatitis: standardized treatment for mild cases, minimally invasive drainage of pseudocysts.
Comprehensive diagnosis and treatment of pancreatic cancer: reduction of jaundice obstruction, interventional targeted therapy, collaboration with Shanghai expert MDT.

(4) Interventional ablation techniques
Radiofrequency/microwave ablation for liver cancer: needle-hole minimally invasive approach, achieving radical effect.
TACE chemotherapy embolization: control of middle-late stage liver cancer, achieving downstaging.
PTCD and biliary stenting: relief of malignant obstructions, liver function protection and jaundice reduction.

(5) ERAS rapid recovery system
Liver, gallbladder, and pancreas-specific ERAS pathways: simplified preoperative preparation, early postoperative mobilization and feeding, shortened hospital stay, reduced complications.

Gallbladder multiple stones, single-port laparoscopic day surgery for minimally invasive removal.
Patient information: 32-year-old female with multiple gallbladder stones, recurrent right upper abdominal pain, seeking minimally invasive procedure for aesthetic appearance and quick discharge.
Treatment process: Single-port laparoscopic cholecystectomy, with only a small hidden incision at the navel, fully minimally invasive.
Treatment outcome: Got out of bed on the day of surgery, discharged the next day, no obvious abdominal scars, mild pain, no complications.

Elderly patient with huge common bile duct stones, non-invasive endoscopic stone removal through ERCP.
Patient information: 76-year-old elderly with multiple underlying heart and lung diseases, huge common bile duct stones causing obstructive jaundice, unable to tolerate open surgery.
Treatment process: Oral ERCP endoscopic stone fragmentation and removal, no incisions on the body surface, no need for anesthesia or surgery.
Treatment outcome: Stones completely removed in one session, rapid resolution of jaundice, discharged after 3 days post-surgery, no bile duct injury, good postoperative recovery.

Solid pseudopapillary tumor at the body and tail of the pancreas, laparoscopic spleen-preserving minimally invasive resection.
Patient information: 44-year-old female with low-grade malignant solid pseudopapillary tumor at the body and tail of the pancreas, requesting minimally invasive procedure with spleen preservation.
Treatment process: Laparoscopic resection of the pancreatic body and tail tumor + spleen-preserving surgery.
Treatment outcome: Complete tumor resection, intact spleen function, discharged after 4 days post-surgery, no damage to pancreatic endocrine function, long-term follow-up shows no recurrence.

Gynecology

Dr. Ying Xiaoyan (Chief of Obstetrics and Gynecology, Discipline Leader, PhD Supervisor)
Dr. Song Hongjuan (Chief of Gynecology, Chief Physician, Master's Supervisor)
Dr. Li Deming (Head of Obstetrics Department, Chief Physician)

Scope of treatment

Benign gynecological tumors: uterine fibroids, ovarian cysts, teratomas, chocolate cysts, cervical polyps.
Uterine cavity diseases: endometrial polyps, submucosal fibroids, intrauterine adhesions, uterine septum, abnormal uterine bleeding, retained products of conception.
Cervical diseases: HPV infection, cervicitis, cervical precancerous lesions, LEEP conization, early screening and prevention of cervical cancer.
Malignant gynecological tumors: cervical cancer, endometrial cancer, ovarian cancer, vulvar cancer, tumor comprehensive MDT management.
Reproductive endocrinology: menstrual disorders, amenorrhea, polycystic ovary syndrome, premature ovarian failure, hyperprolactinemia, perimenopausal/menopausal syndrome.
Pelvic floor dysfunction: stress urinary incontinence, uterine/vaginal prolapse, postpartum pelvic floor injuries, rectus abdominis diastasis, chronic pelvic pain.
Endometriosis: ovarian endometrioma, deep infiltrating endometriosis, comprehensive diagnosis and treatment of dysmenorrhea.
Reproductive tract anomalies: uterine malformations, congenital vaginal developmental abnormalities, corrective surgery for rudimentary uterus, etc.
Inflammation and intimate care: vaginitis, pelvic inflammatory disease, vulvar and vaginal lesions, intimate aesthetic maintenance.
Ectopic pregnancy, investigation of causes of infertility related to uterine cavity, gynecological trauma and repair of postoperative complications.

(1) Gynecological Endoscopic Minimally Invasive System
1. Hysteroscopic Minimally Invasive: through the vaginal route, for treating submucosal fibroids, polyps, intrauterine adhesions, uterine septum, etc., and investigating the causes of infertility; 2. Laparoscopic Minimally Invasive: multi-port/single-port/NOTES scarless surgery, for myomectomy, ovarian cystectomy, endometriosis excision, etc.; 3. Exclusive to Nanjing General Hospital: Da Vinci Xi robot-assisted minimally invasive surgery, used for complex gynecological malignant tumors and other difficult surgeries, precise minimally invasive procedures.


(2) Standardized Diagnosis and Treatment of Gynecological Tumors
Perform radical surgeries for cervical, uterine, ovarian, and vulvar cancers, as well as lymph node dissection; MDT multidisciplinary comprehensive management, covering surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy, etc.; Stepwise prevention and control of cervical precancerous lesions (TCT/HPV screening → colposcopy → LEEP cone biopsy); Preservation of fertility in young patients.


(3) Comprehensive Management of Reproductive Endocrine and Menstrual Disorders Throughout the Cycle
Precise diagnosis and treatment of polycystic ovary syndrome, abnormal uterine bleeding, premature ovarian insufficiency, etc.; Hormone replacement therapy and chronic disease prevention for perimenopausal syndrome; Comprehensive management and control of endometriosis, primary dysmenorrhea.


(4) Pelvic Floor Dysfunction and Postpartum Rehabilitation System
Perform minimally invasive suspension procedures for urinary incontinence such as TVT/TVT-O, pelvic organ prolapse repair; One-stop rehabilitation for postpartum pelvic floor muscles, rectus abdominis separation, etc.; Private cosmetic surgery, correction of benign vulvar lesions, and diagnosis and treatment of chronic pelvic pain.


(5) Correction of Reproductive Tract Malformations and Difficult Gynecological Corrections
Minimally invasive correction of congenital reproductive tract malformations such as vaginal agenesis, double uterus, etc.; Repair of old perineal lacerations, restoration of gynecological postoperative adhesions and complications from surgeries performed elsewhere.


(6) Gynecological Inflammation and Daytime Minimally Invasive Diagnosis and Treatment
Standardized treatment of vaginitis, pelvic inflammatory disease, etc.; Perform LEEP cone biopsy, daytime hysteroscopy/single-port laparoscopy, with same-day surgery and discharge on the same day/next day.

1. Removal of giant uterine fibroid through single-incision scarless laparoscopy
A 32-year-old unmarried female with multiple giant uterine fibroids (largest 9cm), experiencing pelvic pressure and heavy menstrual bleeding, requested a scarless abdominal procedure to preserve the uterus and fertility. The team performed a single-incision laparoscopic uterine fibroid removal surgery, with only a concealed small incision at the navel. The entire fibroid was completely removed with minimal intraoperative bleeding. The patient was discharged 2 days post-surgery with no visible abdominal scars, normal menstrual recovery, no impact on future fertility, and no recurrence during follow-up.

2. Robot-assisted radical surgery for advanced ovarian cancer
A 56-year-old female with advanced epithelial ovarian cancer accompanied by extensive pelvic metastasis and severe adhesions, making traditional open surgery highly traumatic. Director Wang Jing’s team utilized the Da Vinci robot for comprehensive staging and radical surgery for ovarian cancer, meticulously clearing lymph nodes, completely excising the tumor, and accurately protecting surrounding organs. The patient experienced rapid postoperative recovery, received adjuvant therapy, and maintained stable survival during long-term follow-up, significantly improving her quality of life.

3. Hysteroscopic non-invasive separation for severe intrauterine adhesions
A 29-year-old female with severe intrauterine adhesions, amenorrhea, and infertility following previous unsuccessful surgeries at another hospital. Precise separation of adhesions using high-definition hysteroscopy was performed, followed by sequential hormonal endometrial support postoperatively. The uterine cavity morphology returned to normal, menstrual cycles resumed, and successful conception was achieved in subsequent fertility planning.

Gastroenterology

Lü Shengxiang (Chief Physician, Doctor of Medicine, Master's Supervisor)
Zhuge Yuzheng (Chief Physician, Doctor of Medicine, Doctoral Supervisor)
Gu Kaihua (Chief Physician)

Scope of treatment

Gastrointestinal diseases: gastric cancer, gastrointestinal stromal tumor, gastric ulcer perforation, gastric polyps, hiatal hernia, gastric prolapse, pyloric obstruction.
Colorectal diseases: colon cancer, rectal cancer, intestinal adenoma, intestinal polyps, diverticulitis, intestinal obstruction, intestinal adhesions, intestinal fistula.
Early gastrointestinal cancer: high-grade dysplasia in esophagus, stomach, and colorectal, early cancerous changes (endoscopic submucosal dissection for radical cure).
Inflammatory bowel disease: Crohn’s disease, ulcerative colitis and surgical complications.
Abdominal wall hernia surgery: inguinal hernia, incisional hernia, umbilical hernia, parastomal hernia, minimally invasive repair for recurrent hernia.
Abdominal emergency: gastrointestinal perforation, acute intestinal obstruction, abdominal trauma, abdominal infection.
Others: pelvic floor defecation dysfunction, repair of postoperative gastrointestinal complications, nutritional metabolism assessment and rehabilitation.

1. The full spectrum of minimally invasive diagnosis and treatment for gastric diseases
Laparoscopic gastric and duodenal surgery: Conduct single-port / multi-port laparoscopic surgery, accurately remove lesion tissues, with small trauma and fast recovery, suitable for the treatment of benign and malignant gastric and duodenal diseases.
Endoscopic diagnostic and therapeutic techniques: Regularly perform gastroscopy, colonoscopy examinations and treatments, accurately screen for gastrointestinal lesions, achieve early detection and intervention, and reduce misdiagnosis rates.
Management of complex gastrointestinal cases: For complex gastrointestinal diseases and postoperative complications, establish a multidisciplinary team (MDT) to provide standardized diagnostic and treatment plans.


2. Precision diagnosis and treatment of liver, gallbladder, and pancreatic diseases
Liver diseases: Perform laparoscopic liver resection, minimally invasive treatment for liver cysts, accurately protect liver function, and reduce postoperative complications.
Biliary diseases: Implement laparoscopic + choledochoscopy combined treatment, without T-tube placement, to reduce trauma.
Pancreatic diseases: Conduct laparoscopic and interventional treatments, combined with MDT consultations, to achieve precision diagnosis and treatment.


3. Core techniques of digestive endoscopy
Routine endoscopic examinations: Screen for gastrointestinal lesions and guide precise treatment.
Therapeutic endoscopy: Perform polypectomy, stricture dilation, stent implantation, etc., to achieve non-invasive / minimally invasive diagnosis and treatment.


4. Supporting technical guarantees
Advanced equipment support: Equipped with high-definition endoscopes, imaging devices to ensure diagnostic and treatment accuracy.
Fast recovery system: Optimize preoperative preparation, postoperative care, shorten hospitalization periods, and enhance the diagnostic and treatment experience.
Academic research and follow-up: Conduct clinical research, establish patient follow-up records, and achieve standardized management throughout the process.

Ultra-low rectal cancer radical surgery with sphincter preservation at the limit
A 52-year-old male with rectal adenocarcinoma located only 2.5cm from the anal verge was deemed unable to preserve the anus and was advised to have a permanent stoma by another hospital. Director Zhang Yexin’s team performed laparoscopic TME total mesorectal excision + modified low anterior resection, meticulously preserving the pelvic floor nerves and bowel function. The tumor was completely eradicated, the anus was successfully preserved without the need for a stoma, and the patient was discharged after 7 days post-surgery. Follow-up showed no recurrence or anastomotic complications.

Advanced gastric cancer laparoscopic D2 radical surgery
A 64-year-old male with advanced adenocarcinoma of the gastric antrum with lymph node metastasis and invasion of the muscle layer. Laparoscopic distal gastric cancer D2 radical surgery + gastrointestinal reconstruction was performed to achieve R0 resection by thorough lymph node clearance. The patient recovered rapidly post-surgery and had long-term disease-free survival after adjuvant therapy.

Laparoscopic minimally invasive resection of a giant gastric stromal tumor
A 45-year-old female with a huge 8cm gastric stromal tumor at the gastric fundus was afraid of open surgery. A 4K fluorescence laparoscope was used for precise tumor resection, preserving the intact gastric wall and function. The patient was discharged after 4 days post-surgery and had no recurrence during follow-up.

Respiratory Medicine

Wang Cheng (Respiratory Department Director, Chief Physician, PhD)
Xu Xingxiang (Chief Physician, Professor, Postdoctoral Supervisor)
Cai Jiankang (Chief Physician, Associate Professor)
Lin Yong (Chief Physician, Professor, PhD)

Scope of treatment

Lung Nodule Specialty: Ground-glass nodule, Solid nodule, Mixed nodule, Early cancer screening, Benign and malignant differentiation, Minimally invasive interventional ablation.
Chronic Airway Diseases: Chronic obstructive pulmonary disease (COPD), Bronchial asthma (including severe refractory asthma), Chronic bronchitis, Bronchiectasis.
Respiratory Intervention and Airway Diseases: Airway tumors, Benign and malignant airway stenosis, Large airway obstruction, Hemoptysis, Airway foreign body, Tracheoesophageal fistula.
Infectious Lung Diseases: Community / hospital-acquired pneumonia, Severe pneumonia, Fungal lung disease, Viral pneumonia, Recurrent respiratory tract infections.
Interstitial Lung Diseases: Pulmonary fibrosis, Allergic pneumonia, Connective tissue-related lung diseases.
Sleep Breathing Disorders: Snoring, Obstructive sleep apnea-hypopnea syndrome (OSAHS), Nocturnal hypoxemia.
Respiratory Critical Illness: ARDS Acute Respiratory Distress Syndrome, Severe asthma, Respiratory failure, ECMO life support.
Others: Chronic cough, Allergic cough, Pleural diseases, Pneumothorax, Pulmonary rehabilitation, Home oxygen therapy and ventilation management.

(1) Precise management of pulmonary nodules
Establish a multidisciplinary (MDT) tiered diagnosis and treatment system involving respiratory, thoracic surgery, imaging, etc., to achieve early interception of lung cancer. Core technologies include thin-section CT three-dimensional reconstruction, nodule AI intelligent analysis, malignant risk scoring; CT-guided lung biopsy, bronchoscopy (EBUS/ENB) biopsy; early lung cancer radiofrequency/microwave ablation (minimally invasive); establish a lifelong tiered follow-up system to avoid excessive examinations and surgeries.


(2) Respiratory intervention and minimally invasive bronchoscopy techniques
The Nanjing General Hospital has a leading advantage, with synchronous operations in Suzhou. It covers integrated flexible and rigid bronchoscopy, airway tumor resection and granulation tissue ablation, airway stent placement/balloon dilation; electromagnetic navigation bronchoscopy (ENB) for precise diagnosis and treatment of peripheral small nodules; bronchial artery embolization for treating massive hemoptysis; removal of airway foreign bodies, closure of tracheobronchial fistulas.


(3) Chronic management of COPD and asthma
Following international guidelines, conducting lung function tests, FeNO measurements, allergen skin prick tests; personalized stepwise medication, including targeted biologic therapy for severe refractory asthma; establishing chronic disease records, combining pulmonary rehabilitation training, non-invasive ventilation support to delay lung function decline, and reduce acute exacerbations.


(4) Treatment of pulmonary infections and difficult respiratory diseases
Precise diagnosis and treatment of community-acquired pneumonia, severe pneumonia, fungal lung diseases, bronchiectasis, etc.; implementing tiered anti-infective treatment and airway clearance comprehensive therapy for recurrent chronic cough, interstitial lung diseases (pulmonary fibrosis).


(5) Integrated diagnosis and treatment of sleep breathing disorders
Diagnosing OSAHS through polysomnography (PSG), using lifestyle interventions, oral appliances, and stepwise treatment with non-invasive ventilators to address snoring, apnea, and prevent related complications.


(6) Critical care for respiratory emergencies (top in the province at Nanjing General Hospital)
Establishing a respiratory critical care unit, providing invasive/non-invasive mechanical ventilation, high-flow oxygen therapy, and the ability to perform ECMO extracorporeal membrane oxygenation to treat severe pneumonia, ARDS, respiratory circulatory failure, and other critical emergencies, offering comprehensive life-saving treatment.

Deep pulmonary small nodules ENB non-invasive ablation cure
Patient information: 54 years old, during a physical examination, an 8mm ground-glass pulmonary peripheral small nodule was found, located deep, close to the pleura, not reachable by regular bronchoscopy.
Diagnosis and treatment process: Using electromagnetic navigation bronchoscopy (ENB) for precise lesion localization, simultaneously performing biopsy + radiofrequency ablation, throughout the procedure non-invasive, without chest wall incision.
Treatment outcome: Lesion completely inactivated, discharged 2 days after surgery, no complications, no recurrence during follow-up.
Case 2: Severe refractory asthma targeted therapy

42-year-old female, suffering from severe refractory asthma for over 10 years, high-dose steroids were ineffective, frequent acute attacks, waking up at night feeling suffocated.
Diagnosis and treatment process: Improved FeNO testing, allergen screening, personalized treatment using anti-IgE targeted biologics (omalizumab).
Treatment outcome: Asthma completely controlled, steroids gradually reduced and discontinued, no acute attacks, significant improvement in quality of life.

Emergency management of malignant airway stenosis
Patient information: Lung cancer invading the main trachea, airway stenosis 90%, experiencing difficulty breathing, unable to lie flat, on the verge of suffocation.
Diagnosis and treatment process: Tumor ablation under rigid bronchoscopy + placement of covered stent, rapidly opening the airway.
Treatment outcome: Airway immediately unobstructed, relief of breathing difficulty, no need for thoracotomy, rapid postoperative recovery and discharge.

Traditional Chinese Medicine

Liu Jun (Chief Physician of Traditional Chinese Medicine, Professor)
Pan Yucheng (Attending Physician, Doctor of Medicine)
Hu Lie (Chief Physician, Professor, Doctoral Supervisor)
Wang Zhongshan (Chief Physician, Associate Professor)

Scope of treatment

Internal Medicine of Traditional Chinese Medicine: diseases of the spleen and stomach, dampness and phlegm, chronic diseases of the three highs, insomnia and anxiety, long-term cough due to lung deficiency, recurrent colds, easy fatigue due to physical weakness, deficiency of qi and blood.
Gynecology of Traditional Chinese Medicine: irregular menstruation, dysmenorrhea with cold uterus, polycystic ovary syndrome, menopausal syndrome, postpartum physical weakness, endocrine disorders.
Acupuncture for Pain: pain in the neck, shoulders, lower back, and legs, cervical spondylosis, lumbar spondylosis, frozen shoulder, joint degeneration, migraine, facial paralysis, meridian blockage and strain.
Orthopedics and Traumatology of Traditional Chinese Medicine: muscle strain, stiff fascia, postural imbalance, cold and damp joint pain.
Sub-healthy State Prevention and Treatment: imbalance of the nine constitutions, overuse due to staying up late, lack of energy, accumulation of dampness, physical weakness due to overwork, health preservation and strengthening the foundation.
Traditional Chinese Medicine Regulation for Tumors: postoperative/supportive treatment after radiotherapy/chemotherapy, reducing side effects, enhancing immunity, and preventing recurrence.
Special External Treatments: three-seven-three-nine herbal patches, moxibustion therapy, gua sha and cupping therapy, ear acupoint regulation, and acupoint embedding.
Seasonal Health Preservation: personalized herbal prescriptions, dietary therapy, and guidance on seasonal routines for health preservation.

1. Traditional Chinese medicine focuses on regulating the organs and strengthening the body.
Core techniques: Precise combination of pure Chinese herbal decoctions, ready-to-use granules, and authentic medicinal herbs, covering diseases of the spleen and stomach, chronic internal diseases, gynecological disorders, etc. Treatment based on the differentiation of syndromes according to the Six Meridian Systems, suitable for various constitutions.
Key areas: Diseases of the spleen and stomach (chronic gastritis, indigestion, etc.), chronic internal diseases (hypertension, hyperlipidemia, etc.), gynecological disorders (menstrual issues, cold uterus, etc.), achieving treatment based on syndrome differentiation and addressing the root cause.


2. Non-invasive therapy system of acupuncture and meridian channels.
Integrating traditional filiform acupuncture, intangible cultural heritage acupuncture, Dong’s extraordinary acupoints, electroacupuncture, etc., to accurately regulate the meridians, promote qi circulation and blood flow, suitable for neck, shoulder, back, and leg pain, insomnia, endocrine disorders, etc.
Special techniques: Acupoint embedding, heat-sensitive moxibustion, Du meridian fire dragon moxibustion, non-invasive and free of side effects, suitable for all populations.


3. Ancient moxibustion and external treatment system.
Utilizing techniques such as heat-sensitive moxibustion, suspended moxibustion, ginger-separated moxibustion, to warm the meridians, dispel cold and dampness, tonify yang and strengthen the body, covering scenarios of cold and dampness, yang deficiency, postpartum care, etc.


4. Traditional Chinese medicine external treatment and health preservation system.
Including Chinese herbal fumigation, acupoint application (summer heat-clearing patches, winter-warming patches), tuina massage, myofascial release, achieving non-invasive/minimally invasive therapy.
Preventive treatment and health preservation: Constitution identification, customized seasonal herbal plasters, dietary therapy guidance, establishing comprehensive follow-up management.

Acupuncture + ear acupoint therapy for severe insomnia and anxiety
Patient: 45 years old, long-term difficulty falling asleep, frequent dreams and easy awakening, accompanied by irritability and anxiety, dependent on sleeping pills, relapse upon discontinuation.
Treatment: Using meridian differentiation acupuncture + ear acupoint pressing to soothe the liver and calm the mind, combined with nourishing yin and calming the spirit herbal medicine.
Outcome: Freed from dependence on sleeping pills, significantly improved sleep quality, stable emotions, and restored energy.

Traditional Chinese medicine treatment for menopausal syndrome
Patient: 50-year-old female, experiencing hot flashes, night sweats, irritability, and refusing hormone therapy.
Treatment: Diagnosed as liver and kidney yin deficiency, liver qi stagnation, prescribed blood-nourishing and liver-soothing, kidney-tonifying and yin-nourishing herbal medicine, combined with moxibustion for warming and nourishing.
Outcome: Hot flashes and night sweats disappeared, stable emotions, improved menstrual irregularities, and returned to normal life.

Acupuncture treatment for lumbar disc herniation
Patient: 42 years old, with long-term lumbar muscle strain, lumbar degeneration, significant lower back pain after prolonged sitting, dependent on painkillers.
Treatment: Using acupuncture to unblock meridians, release fascia, combined with infrared therapy, and simultaneously adjusting body posture.
Outcome: Lower back pain completely relieved, posture restored, no need for long-term use of painkillers, no recurrence during follow-up.

Radiology

Key disciplines in clinical specialty cultivation in Jiangsu Province, key medical specialties in Nanjing City, national standardized unit for radiological quality control, core unit of Jiangsu Imaging Quality Control Alliance, Nanjing Imaging Diagnosis Center, teaching base for master’s and doctoral programs at Nanjing Medical University, hospital-wide multidisciplinary MDT imaging support center, cross-strait imaging medical cooperation platform, and the Yangtze River Delta comprehensive imaging consultation center for difficult systemic diseases.

Directorial team: Leading authority in the field of imaging in Jiangsu Province, specializing in imaging diagnosis for over 30 years, proficient in precise staging of systemic tumor imaging, neurovascular imaging, abdominal hepatic biliary urinary imaging, musculoskeletal imaging, cardiovascular large vessel imaging, and differential diagnosis of rare and difficult imaging cases.

Key backbone teams in sub-specialties: Neuroimaging, thoracic imaging, abdominal-pelvic imaging, musculoskeletal imaging, cardiovascular imaging, interventional imaging, ultrasound imaging, nuclear medicine PET imaging, and AI imaging analysis physicians are fully equipped; an ample team of master’s and doctoral degree holders, supported by imaging technicians, equipment engineers, and records quality control officers, ensuring a comprehensive hospital-wide imaging quality control system.

Scope of treatment

Imaging of the chest: pulmonary nodules, lung cancer, pneumonia, chronic obstructive pulmonary disease (COPD), mediastinal lesions, chest wall, pulmonary embolism.
Imaging of the abdomen and pelvis: liver, gallbladder, pancreas, spleen, kidneys, gastrointestinal tract, urinary system, uterus, ovaries, prostate, retroperitoneal lesions.
Imaging of the nervous system, head, skull, and spine: cerebral infarction, intracerebral hemorrhage, brain tumors, intracranial aneurysms, spinal cord lesions, vascular malformations of the brain.
Imaging of bones, joints, and muscles: fractures, joint degeneration, meniscus and ligament injuries, bone tumors, scoliosis, soft tissue lesions.
Imaging of the cardiovascular system and major blood vessels: coronary artery plaques, aortic dissection/aneurysm, pulmonary embolism, systemic arterial and venous vascular diseases.
Imaging of the head, neck, and sensory organs: thyroid, cervical lymph nodes, pharynx, nasal cavity, orbital and inner ear lesions.
Breast imaging: breast masses, microcalcifications, breast tumor screening with BI-RADS classification.
Imaging of systemic tumors: early screening for tumors, differentiation between benign and malignant tumors, staging of systemic tumors, metastasis evaluation, treatment follow-up, recurrence monitoring.
Nuclear medicine whole-body imaging: PET-CT for whole-body tumor metabolic screening, identification of unknown primary cancer sources.
Emergency imaging: trauma, intracranial hemorrhage, aortic emergencies, one-stop rapid imaging diagnosis for acute abdominal conditions.

1. Full modality high-definition imaging diagnostic technology (standard configuration for both hospitals)
Core technology fully covers whole-body spiral CT, 1mm thin-layer scanning, three-dimensional post-processing, functional imaging, accurately completing comprehensive system lesion screening and qualitative analysis; including vascular CTA, organ-enhanced scanning, three-dimensional reconstruction, as well as conducting DR, molybdenum target, ultrasound examinations, including ultrasound elastography, intraoperative ultrasound guidance, meeting the diagnostic needs in all scenarios.


2. Precision tumor imaging throughout the entire cycle technology (core advantage)
Provides support for the entire process of tumor diagnosis and treatment, covering precise analysis of lung nodules, systemic tumor infiltration and lymph node staging, delineation of radiotherapy target areas, assessment of treatment follow-up, and screening for systemic occult metastases, achieving precise control of tumor diagnosis and treatment throughout the entire cycle.


3. AI artificial intelligence-assisted imaging diagnostic system (synchronized for both hospitals)
Deploying a comprehensive medical AI platform, capable of automatically detecting lung nodules, breast microcalcifications, acute cerebral infarction, and other lesions, automatically completing risk scoring, grading, and comparing new and old lesions, reducing misdiagnosis and missed diagnosis rates, and improving diagnostic efficiency.


4. Intraoperative imaging navigation and interventional imaging support (special feature of the Nanjing General Hospital)
The hybrid operating room can achieve real-time DSA intraoperative angiography, surgical navigation, accurately locating lesions in the liver, gallbladder, pancreas, cardiovascular system, etc.; also providing interventional radiology path planning, CT/ultrasound-guided biopsy, supporting various surgeries and interventional treatments.
5. Precision diagnosis of cardiovascular large vessel imaging (core advantage of Nanjing)
Conducting coronary artery, aorta, and pulmonary artery CTA examinations, accurately identifying coronary artery stenosis, aortic dissection, pulmonary embolism, and other lesions, providing precise imaging support for the diagnosis and treatment of cardiovascular diseases.
6. Fine diagnosis of neurovascular imaging
Accurately detecting lesions such as acute cerebral infarction, cerebral hemorrhage, brain tumors, cerebral vascular malformations, while evaluating cerebral small vessel disease, brain atrophy, providing precise imaging basis for the diagnosis and treatment of neurology and neurosurgery.

Whole-body PET-CT traces the origin of hidden tumors
Patient condition: Multiple enlarged lymph nodes throughout the body, elevated tumor markers, primary lesion cannot be located by conventional CT/MRI.
Diagnosis and treatment process: Using PET-CT for whole-body metabolic imaging, relying on the high metabolic characteristics of tumors, accurately detects tiny primary tumors in the throat, clarifies the extent of systemic metastasis and staging.
Treatment effect: Successfully identifies the primary lesion, provides precise basis for formulating curative treatment plans for tumors, avoids blind treatment, significantly improves diagnostic and treatment efficiency.

One-stop imaging + interventional treatment for acute ischemic stroke
Patient condition: Sudden hemiplegia and aphasia, admitted to the emergency department.
Imaging diagnosis and treatment: Rapid completion of head CT, brain vascular CTA, DWI sequence imaging, accurately locates the site of vascular occlusion and ischemic range.
Interventional treatment: Balloon dilatation guided by DSA to open the occluded blood vessel, simultaneous thrombolysis, stent implantation, rapidly restore blood supply, buy time for subsequent treatment.

AI precise assessment of ground-glass lung nodules
Patient condition: Discovered an 8mm ground-glass nodule during a physical examination, difficulty in determining benign or malignant nature.
Imaging diagnosis and treatment: Thin-section CT scan + AI intelligent analysis, combined with pathological biopsy, accurately determines the nature of the nodule, avoids unnecessary surgery, and formulates personalized follow-up plans to reduce recurrence rate.

Scroll to Top
Dr. Fei Zhewei
 
Title
 
Vice President of Thyroid and Breast Center, Suzhou BenQ Hospital, MD, Chief Physician, Professor
 
Department
 
Department of Thyroid Surgery
 
Professional Experience
 
  • Vice President of Thyroid and Breast Center, Suzhou BenQ Hospital
  • Vice President of Nanjing BenQ Hospital, Director of Breast Disease Diagnosis and Treatment Center
  • Senior Expert of Breast Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
  • Consultant and Founding Director of Breast Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
  • Former Director of Shanghai Key Specialty (Thyroid and Breast Surgery, Chongming Branch of Xinhua Hospital)
  • Studied at Massachusetts General Hospital, Harvard University, USA for two years
 
Clinical Specialties
 
Engaged in clinical diagnosis and treatment of thyroid and breast diseases for more than 40 years. Specializes in various surgical procedures and comprehensive treatments for thyroid diseases and breast cancer.
 
Has performed thousands of surgeries for thyroid cancer and breast cancer with excellent outcomes, and the vast majority of patients have achieved long-term survival, enjoying a high reputation.
 
As a pioneer of endoscopic surgery at Xinhua Hospital, he took the lead in performing endoscopic minimally invasive thyroidectomy and gynecomastia resection at Shanghai Xinhua Hospital.
 
Professional Memberships
 
  • Chairman, Health Management Committee, Chinese Association of Rehabilitation Medicine
  • Leader of Breast Disease Group, Health Management Committee, Chinese Association of Rehabilitation Medicine
  • Consultant and Former Vice Chairman, Enteral and Parenteral Nutrition Society, Shanghai Medical Association
  • Member, Thyroid Surgery Branch, Chinese Medical Doctor Association
  • Member, Thyroid Postoperative Management Committee, Chinese Research Hospital Association
 
Awards & Honors
 
  • Shanghai May 1st Labor Medal
  • Shanghai Advanced Worker

Wu Yanmei
Associate Chief Physician
Education: Master of Medicine
Department: Thyroid Surgery
Main Experience:
Associate Chief Physician, Breast Surgery Department, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Specialties:
With over 20 years of work experience, worked in the Thyroid and Breast Surgery Department of Shanghai Changhai Hospital for 15 years, has rich experience in thyroid surgery. Proficient in ultrasound-guided thyroid puncture, thyroid radiofrequency ablation, surgery and comprehensive treatment of thyroid benign and malignant tumors, etc.

Social Positions:
Member of the Youth Committee of the Shanghai Anti-Cancer Association Breast Cancer Specialty
Director of the Shanghai Eugenics and Eugenics Science Association (Shanghai Maternal and Child Health Association)

Research Achievements:
As the first author and corresponding author, published more than ten SC1 articles in domestic and foreign core journals, with a cumulative impact factor of 60 points
Participated as a key member in a National Natural Science Foundation general project
Managed clinical trials for 10 years, participated in dozens of international multicenter and domestic multicenter clinical trials
Co-authored one textbook “Breast Pathology Diagnosis and Differential Diagnosis” published by People’s Medical Publishing House

Dr. Lin Xiaoyan
 
Title
 
Director of Breast Surgery, Suzhou BenQ Hospital, Master of Medicine, Chief Physician
 
Department
 
Department of Breast Surgery
 
Professional Experience
 
  • 1988–1993: Clinical Medicine, Shanghai Second Medical University
  • 1993–2025: Department of Breast Surgery, Yangpu Hospital Affiliated to Tongji University
  • 2009–2025: Director of Department of Breast Surgery, Yangpu Hospital Affiliated to Tongji University
  • 2020: Served as Director of the first batch of pilot centers for standardized diagnosis and treatment quality control of breast cancer under the National Cancer Center
  • Passed the center review in April 2024
 
Clinical Specialties
 
Diagnosis and treatment of common breast diseases and complicated disorders, including acute and chronic mastitis, breast nodules, hyperplasia of mammary glands, breast cancer and other diseases.
 
Especially proficient in early diagnosis of breast tumors, various breast cancer surgeries, individualized comprehensive treatment of breast cancer, and diagnosis and treatment of intraductal diseases such as nipple discharge.
 
Professional Memberships
 
  • Member, Breast Cancer Committee, Shanghai Anti-Cancer Association
  • Member, Oncology Branch, Shanghai Medical Doctor Association
  • Member, Breast Disease Committee, Shanghai Association of Integrated Traditional Chinese and Western Medicine
  • Standing Member, Thyroid and Breast Surgery Committee, Shanghai Association of Integrated Traditional Chinese and Western Medicine
  • Member, Breast Disease Prevention and Treatment Committee, Shanghai Association for Better Birth and Childcare
  • Standing Member, Breast Health Management and Science Popularization Expert Committee, Health Science Branch, Shanghai Science and Technology Popularization Volunteer Association
  • Standing Member, Breast Committee, Shanghai Female Medical Doctor Association
  • Member, Day Chemotherapy Group, Day Surgery Management Committee, Shanghai Hospital Association
  • Standing Member, Intelligent Diagnosis and Treatment Committee for Thyroid and Breast Diseases and Rare Diseases, Shanghai Biomedical Industry Association
  • Vice Chairman, Breast Disease Committee, Shanghai Yangpu Medical Association
 
Research Achievements
 
In recent years, presided over a number of projects from Shanghai Municipal Health Commission and district-level research funds.
 
Presided over and participated in many domestic multi-center clinical research projects.
 
Published more than 30 academic papers in core and SCI journals.

Please leave your name and contact information, and our medical tourism consultant will contact you within 12 hours. Thank you for your inquiry!

Medical Tourism in China | Suzhou Fenglin International
Dr. Li Weijie
 
Title
 
MD, Professor
 
Senior Bariatric & Metabolic Surgery Expert
 
Education
 
  • MD, Institute of Clinical Medicine, National Taiwan University
  • Visiting Professor, University of California, Los Angeles, USA
  • Research Fellow, Cancer Institute Hospital of Tokyo, Japan
 
Professional Experience
 
  • CEO, Asia Pacific Endoscopic Bariatric & Metabolic Surgery Center
  • Chairman, Asian Diabetes Surgery Group
  • Executive President, Min-Sheng General Hospital
  • Adjunct Professor of Surgery, College of Medicine, National Taiwan University
  • Adjunct Professor of Surgery, College of Medicine, National Cheng Kung University
  • Founding President, Taiwan Society for Metabolic & Bariatric Surgery
  • Founding President, Asia Pacific Society for Metabolic & Bariatric Surgery
 
Clinical Specialties
 
  • Pioneer in endoscopic gastrointestinal surgery and founder of laparoscopic radical gastrectomy
  • Performed Asia’s first laparoscopic bariatric surgery in 1997, known as the “Father of Bariatric Surgery in Asia”
  • Led his team to complete nearly 7,000 cases of laparoscopic bariatric and metabolic surgeries
  • Pioneer in laparoscopic metabolic surgery for type 2 diabetes in Asia since 2005
  • Developed the first clinical guidelines for diabetes surgery in Asia
  • Sole Asian representative in the World Diabetes Surgery Research Program
  • Established the Asian Diabetes Surgery Study Group with leading research data worldwide
 
Research & Academic Achievements
 
  • Published nearly 300 peer-reviewed SCI papers
  • Recognized in 2018 by Obesity Surgery as the world’s most prolific author in bariatric and metabolic surgery
  • Established the Asian Diabetes Surgery Study Group in 2010 and developed Asian consensus guidelines
  • Invited to the EU Headquarters in Brussels in 2010 to draft 2011 global diabetes treatment guidelines, as one of 20 worldwide experts and four Asian representatives
  • Recipient of Best Paper Award and Distinguished Contribution Award from the American Society for Metabolic and Bariatric Surgery, 2011

Mao Zhongqi
Director of Metabolism and Weight Loss Medical Center, Doctoral Supervisor
Education: Further training in weight loss and diabetes surgery at the University of California, USA, and Taiwan Yida Hospital

Department: Metabolism and Weight Loss Medical Center

Specialties: Surgical treatment of morbid obesity and type 2 diabetes

Education:
– Further training in weight loss and diabetes surgery at the University of California, USA, and Taiwan Yida Hospital

Work Experience:
– Head of General Surgery at Suzhou Affiliated Hospital I, Chief Physician, Clinical Doctoral Supervisor

Areas of Expertise:
– Surgical treatment of morbid obesity and type 2 diabetes, pioneering various weight loss surgeries in China with rich experience and good results
– Metabolic weight loss surgery
– Precise single anastomosis gastric bypass surgery
– Symmetrical three-hole sleeve gastrectomy
– Diabetes surgery
– Weight loss revision surgery
– Radical gastrectomy for gastric cancer, sphincter-preserving surgery for rectal cancer
– Other laparoscopic surgeries (such as cholecystectomy, splenectomy, etc.)
– Diagnosis and treatment of digestive tumors, particularly research on radical gastrectomy for gastric cancer and sphincter-preserving surgery for rectal cancer
– Rich experience in using laparoscopy to treat general surgical diseases such as cholecystectomy, colorectal resection, splenectomy, etc.

Publications:
– Led several provincial and ministerial-level scientific research projects. Published multiple papers in SCI, EI sources, and core journals. Received provincial medical new technology introduction award.

Committee Memberships:
– Member of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
– Member of the American Society for Metabolic and Bariatric Surgery (ASMBS)
– Executive Committee Member of the Chinese Society for Metabolic and Bariatric Surgery (CSMBS) Second Session
– Executive Committee Member of the Chinese Healthcare International Exchange Promotion Association Metabolic and Bariatric Surgery Branch First Session
– Committee Member of the Chinese Research Hospital Association Diabetes and Obesity Surgery Professional Committee
– Editor of the Chinese Journal of Obesity and Metabolic Diseases
– Deputy Director of the Obesity and Diabetes Surgery Group of the Jiangsu Medical Association

Dr. Xu Weiting
 
Title
 
Director of Department of Cardiovascular Medicine
 
Education
 
  • Bachelor of Medicine, Medical College of Shihezi University (1988–1993)
  • Master of Medicine, Peking University Health Science Center (2000–2003)
  • Exchange Scholar, University Hospital of Freiburg, Germany (2005–2006)
  • The 3rd Advanced Training Program for Department Directors, Harvard Medical School, USA (2017)
 
Department
 
Department of Cardiovascular Medicine
 
Professional Experience
 
  • 1993–2000: Resident and Attending Physician, Department of Cardiology, First Affiliated Hospital of Medical College of Shihezi University
  • 2003–2019: Associate Chief Physician, Chief Physician, Associate Professor, Department of Cardiology, The Second Affiliated Hospital of Soochow University
 
Clinical Specialties
 
  • Focused on basic and clinical research of coronary heart disease and arrhythmia.
  • Proficient in the diagnosis and treatment of common, frequently occurring cardiovascular diseases and some complicated disorders.
  • Particularly experienced in interventional diagnosis and treatment of coronary heart disease and arrhythmia.
  • Completed more than 7,000 interventional procedures in total.
  • Skilled in interventional therapy for complex coronary artery lesions and emergency intervention for acute myocardial infarction.
  • Proficient in radiofrequency ablation for tachyarrhythmia and implantation of various cardiac pacemakers.
 
Professional Memberships
 
  • Member, International Liaison and Exchange Committee, Cardiovascular Branch, Chinese Medical Doctor Association
  • Member, Thrombosis Working Committee, Chinese Medical Association
  • Member, Cardiovascular Branch, Jiangsu Medical Association
  • Standing Member, Cardiovascular Professional Committee, Jiangsu Association of Integrated Traditional Chinese and Western Medicine
  • Member, Heart Failure Group, Jiangsu Province
  • Vice Chairman, Chest Pain Professional Committee, Suzhou City
  • Member, Cardiovascular Branch, Suzhou Medical Association
  • Verification Expert, Chest Pain Center, Chinese Chest Pain Professional Committee
  • Verification Expert, Heart Failure Center, Chinese Heart Failure Professional Committee
  • Member, Verification Expert Committee, National Standardized Hypertension Control Center
  • Member, Cardiovascular Professional Committee, National Non-Public Medical Institutions Association
  • Member, Coronary Heart Disease Group, Jiangsu Association of Integrated Traditional Chinese and Western Medicine

Shi Cheng
Deputy Chief Physician, Department of Cardiology
Education: Graduated from the Clinical Medicine Department of Soochow University in 2004

Department: Heart Center

Main Experience:
2004-2018: Department of Cardiology, People’s Hospital of Xiangcheng District, Suzhou

2018-Present: Department of Cardiology, Mingji Hospital, Suzhou

Currently serving as Deputy Director of Cardiovascular Department at Mingji Hospital, Suzhou

Specialties:
Engaged in cardiovascular medical, teaching, and research work for 17 years, with rich experience in the diagnosis and treatment of cardiovascular diseases. Proficient in the diagnosis and treatment of common cardiovascular diseases such as hypertension, coronary heart disease, and heart failure. Specializes in interventional diagnosis and treatment of cardiovascular diseases, with a focus on interventional treatment of arrhythmias. Regularly performs interventions such as coronary angiography, radiofrequency ablation, and pacemaker implantation, achieving good clinical outcomes.

Research:
Published 4 articles in core journals and edited a book on hypertension

Academic Positions:
Council Member of the Chinese Hypertension League

Member of the Coronary Artery Group of the Suzhou Cardiovascular Disease Branch Society

Member of the Echocardiography Group of the Suzhou Cardiovascular Disease Branch Society

Member of the Suzhou Atrial Fibrillation Center Alliance

Dr. Xue Shouru
 
Title
 
MD, Chief Physician, Master’s Supervisor, PhD Supervisor, Professor
 
Education
 
PhD in Neuroscience, Soochow University
 
Department
 
Department of Neurology
 
Professional Experience
 
  • 1997–2000: PhD in Neuroscience, Soochow University
  • Chief Physician (Professor, Master’s Supervisor, PhD Supervisor), The First Affiliated Hospital of Soochow University
 
Clinical Specialties
 
Specializes in the diagnosis and treatment of neurological diseases and symptoms, including dizziness, headache, stroke (paralysis), cognitive impairment (memory disorders and dementia), tremor (Parkinson’s disease), coma, convulsions, aphasia, as well as complicated and difficult neurological disorders.
 
Academic & Social Honors
 
  • Member of Chinese Medical Association
  • 2015: Elected Foreign Member of the Royal Society of Neuroscience, Australia
  • Selected as High-level Talent of Jiangsu Province “333 Project” and “Six Talent Peaks” Program
  • 2018: Elected Member of China-Japan-Korea Alzheimer’s Disease Consortium; Leader of Jiangsu Center, one of the first 18 national demonstration centers of China Cognitive Impairment Consortium
  • National Member of ADC
  • National Member of Vascular Cognitive Impairment Committee, Chinese Medical Doctor Association
  • Director of Jiangsu Stroke Association
  • Chairman of Cognitive and Mental Disorders Committee, Jiangsu Stroke Association
  • Vice Leader of Cognitive Impairment Group, Neurology Branch, Jiangsu Medical Association
  • Vice President of Southern Jiangsu Academy of Cognition
  • Leader of Cognitive Impairment Group, Neurology Branch, Suzhou Medical Association
  • Editorial Board Member and Reviewer for several international journals
  • Member of the Expert Database, Academic Degree Evaluation Center, Ministry of Education
  • Expert of National Natural Science Foundation of China Review Committee
  • Member of Medical Appraisal Expert Database, Jiangsu Medical Association
  • Standing Member of Medical Appraisal Expert Database, Suzhou Medical Association
  • National Member of Vascular Cognitive Impairment Group, China International Exchange and Promotion Association for Medical and Healthcare
  • Vice Chairman of Stroke Rehabilitation Committee, Chinese Rehabilitation Medical Association
 
Main Research Interests
 
Mainly engaged in basic and clinical research in clinical neurology, especially neurodegenerative diseases and vascular cognitive impairment.
 
Research Achievements
 
Presided over 10 national, provincial and ministerial research projects. Published more than 80 academic papers, including 25 SCI papers. Edited or co-edited 4 books. Won more than 10 scientific research achievement awards at the ministerial, provincial and municipal levels.

Ye Min

Chief of Neurology / Chief Physician / Professor / Doctor of Medicine / Master’s Supervisor

Professional Background

Graduated from Shanghai Second Medical University (now Shanghai Jiao Tong University School of Medicine) with a doctoral degree in Neurology. Previously served as the Deputy Chief Physician of Neurology at Nanjing Brain Hospital, currently serving as the Chief of Neurology at Nanjing Mingji Hospital, Professor and Master’s Supervisor at Nanjing Medical University, and Deputy Leader of the Parkinson’s Disease and Movement Disorders Group of the Neurology Branch of the Jiangsu Medical Association.

Core Expertise

Specializes in the diagnosis and treatment of Parkinson’s disease and movement disorders, proficient in the assessment and comprehensive management of Deep Brain Stimulation (DBS) neuroregulation surgery. Also well-versed in the standardized diagnosis and treatment of various difficult neurological diseases such as dementia, cerebrovascular disease, central nervous system infections, and neurodegenerative diseases.

Academic and Clinical Achievements

Published over 30 clinical papers, and contributed to the writing of 5 professional clinical books. Led and participated in multiple research projects, receiving awards from the Ministry of Education and the Shanghai Municipal Science and Technology Commission. Spearheaded the establishment of a multidisciplinary one-stop treatment model for Parkinson’s disease in the department, providing patients with integrated management plans encompassing medication, surgery, and rehabilitation.

Zhang Zengping
Associate Chief Physician, Deputy Director of Medical Affairs

Department: Neurology

Specialties: Diagnosis and treatment of common and prevalent diseases in neurology, mainly focusing on the diagnosis and treatment of dizziness and cerebrovascular diseases. Treatment includes mechanical thrombectomy for ischemic stroke, arterial thrombolysis, and stent implantation for cerebral vascular stenosis.
Education:
Clinical Medicine, Xi’an Jiaotong University School of Medicine

Work Experience:
Neurology Department, PLA 451 Hospital, Attending Physician

Neurology Department, Suzhou Mingji Hospital, Associate Chief Physician

Areas of Expertise:
Diagnosis and treatment of common and prevalent diseases in neurology, specializing in the diagnosis and treatment of dizziness, headaches, epilepsy, early assessment of stroke patients, ultra-early treatment, especially neurointervention, cerebral artery thrombectomy, intracranial and extracranial vascular stenosis, and intervention treatment for chronic cerebrovascular occlusion.

Publications and Works:
Published over 10 papers as the first author or corresponding author, participated in 2 provincial and ministerial-level research projects.

Liu Huiping
Deputy Director, Department of Thoracic Surgery, Mingji Hospital, Taiwan
Specialty: Proficient in clinical research on lung cancer, esophageal cancer, and lung transplantation, thoracoscopic surgery, and robotic surgery. He has deep expertise in minimally invasive thoracoscopic surgery in the field of thoracic surgery, playing a significant role in promoting the development of international thoracic surgery. He is recognized as one of the most outstanding experts in thoracoscopic surgery in Asia, with a high number of surgeries, high success rate, low complication rate, and good survival rate.

Main Experiences:
First President of Mingji Hospital in Nanjing
Professor of Surgery at Chang Gung Memorial Hospital, Taiwan
Deputy Director of Chang Gung Memorial Hospital, Taiwan
Convener of the International Lung Cancer Center at Chang Gung Hospital, Taiwan
President and CEO of Hospital Universiti Kebangsaan Malaysia
Technical Expertise:
With over 40 years of experience in thoracic surgery, he specializes in lung cancer, esophageal cancer, lung transplantation clinical research, thoracoscopic surgery, and robotic surgery.

He is acclaimed for the “Chang Gung Experience” in thoracoscopic surgery, which has gained international recognition in the field of thoracic surgery. He has been invited to give thoracoscopic surgery lectures and demonstrations at major international conferences in the United States, Japan, South Korea, Brazil, India, the Netherlands, and Australia.

Research Achievements:
Since 1992, he has published over 300 papers on minimally invasive thoracoscopic surgery, over 100 related works and SCI papers, including 12 invited chapters in English specialized books and 1 Chinese book (Thoracoscopic Surgery: Clinical Use and Techniques). He has led 24 research projects.
He serves as an editorial board member and reviewer for over ten domestic and international journals, including the American Journal of Thoracic Surgery, American Journal of Respiratory and Critical Care Medicine, American Journal of Chest, American Journal of Thoracic and Cardiovascular Surgery, European Journal of Cardiothoracic Surgery, Chinese Journal of Cardiothoracic Surgery, Chinese Journal of Minimally Invasive Surgery, Asian Cardiovascular and Thoracic Annals, and Asian Journal of Surgery.

Other Positions:
Fellow of the American College of Surgeons (FACS)
Fellow of the American College of Chest Physicians (FCCP)
Member of the Society of Thoracic Surgeons (STS)
Founding Executive President of the International Chinese Society of Thoracic Surgery (ICSTS)
Executive President of the International Chinese Society of Thoracic Surgery
Member of the International Society of Minimally Invasive Surgery
Director of the Asian Thoracoscopic Endoscopic Surgery Society (ATEP)
Executive Director of the Taiwan Society of Thoracic and Cardiovascular Surgery
Executive Director of the Taiwan Society of Endoscopic Surgery

Wei Jingyi
Director of Thoracic Surgery, Chief Physician

Department: Thoracic Surgery

Specialties: Engaged in thoracic surgery for over 40 years, former Chief Physician of Thoracic Surgery at Nanjing Gulou Hospital, joined Nanjing Mingji Hospital in 2014. Proficient in various thoracic surgeries, especially skilled in high-difficulty thoracic surgeries such as esophageal surgery after gastric surgery and tracheal tumor surgery.

Title:
Chief Physician

Main Experience:
1979-2013 Department of Cardiothoracic Surgery, Nanjing Gulou Hospital

Former Director of Cardiothoracic Surgery at Gulou Hospital

Main Treatments:
Engaged in thoracic surgery for over 40 years, former Chief Physician of Thoracic Surgery at Nanjing Gulou Hospital, joined Nanjing Mingji Hospital in 2014. Proficient in various thoracic surgeries, especially skilled in high-difficulty thoracic surgeries such as esophageal surgery after gastric surgery and tracheal tumor surgery.

Expertise: Various surgical treatments for esophageal cancer, such as colon esophagus replacement surgery, jejunal esophagus replacement surgery, post-gastrectomy residual stomach esophageal cancer surgery, etc.; various surgical treatments for lung cancer, such as radical lung cancer surgery, trachea and vascular reconstruction, sleeve resection, total pneumonectomy, etc.; complex funnel chest correction surgery, etc.

Publications:
Published over twenty professional papers in national and provincial medical journals.

Liu Changjian
Chief Physician, Professor, Doctoral Supervisor, Expert Enjoying Special Allowance from the State Council

Education: Professor, Doctoral Supervisor

Department: Thoracic Surgery

Specialties: Proficient in the diagnosis and treatment of various vascular diseases including thoracoabdominal aortic aneurysm, aortic dissection, arterial embolism, arterial sclerosis occlusion, carotid artery stenosis occlusion, aortitis, vasculitis, lower limb varicose veins, deep vein thrombosis, inferior vena cava syndrome, vascular malformations, arteriovenous fistula, dialysis access establishment and maintenance, vascular injuries, and other vascular diseases.

Main Experiences:
Professor, Doctoral Supervisor, Expert Enjoying Special Allowance from the State Council

A nationally renowned vascular surgeon, former Chief Physician and Department Director of Vascular Surgery at Nanjing Drum Tower Hospital, leader of the Vascular Surgery discipline; underwent further training in vascular surgery at the Royal Melbourne Hospital in Australia and St. George Hospital in Leipzig, Germany; previously served as a committee member of the Vascular Surgery Group of the Chinese Medical Association, Chairman of the Vascular Surgery Group of the Jiangsu Medical Association, and Executive Committee Member of the Vascular Surgery Branch of the Chinese Medical Doctor Association.

Chen Shilin
Chief Physician

Department: Thoracic Surgery

Specialties: Proficient in lung nodules, lung tumors, lung metastases, esophageal cancer, mediastinal tumors, precise minimally invasive integrated treatment for advanced thoracic tumors

Main Experience:
Chief Physician of Thoracic Surgery, Professor, Doctoral Supervisor

PhD graduate from the Second Military Medical University

Former Chief Physician of Thoracic Surgery at Jiangsu Cancer Hospital and Deputy Chief Physician of Thoracic Surgery at Nanjing Military Region General Hospital

Main Treatments:
Lung nodules, lung tumors, lung metastases, esophageal cancer, mediastinal tumors, precise minimally invasive integrated treatment for advanced thoracic tumors

Dr. Yu Zhenkun
 

Title

 

Dr. Yu Zhenkun, MD, PhD

 

Chief of Otolaryngology-Head and Neck Surgery, BenQ Hospital Affiliated with Nanjing Medical University

 
Education
 
  • Medical Doctor & PhD, Postdoctoral Fellowship (Beijing Tongren Hospital & Memorial Sloan Kettering Cancer Center, USA)
 
Professional Experience
 
  • Vice Dean, Fourth Clinical Medical College of Nanjing Medical University
  • Professor & PhD Supervisor, Nanjing Medical University
  • Professor, Southeast University School of Medicine
  • Former Chief, Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital
  • Former Deputy Director, Beijing Institute of Otolaryngology
  • Former Professor & PhD Supervisor, Capital Medical University
  • Former President & Chief Expert, Nanjing Tongren Hospital
 
Clinical Specialties
 
  • Complex Otolaryngology-Head and Neck Surgery
  • Obstructive Sleep Apnea (Pediatric & Adult)
  • Precision Laryngeal Surgery (Vocal Cord Paralysis, Cricoarytenoid Joint Reduction)
  • Targeted Treatment for Laryngeal Papilloma
  • CO₂ Laser Minimally Invasive Surgery for Laryngeal Cancer
  • Voice-Preserving Laryngeal Cancer Surgery
  • Precision Thyroid Cancer Surgery
  • Multimodal Therapy for Hypopharyngeal Cancer
  • Salvage Surgery & Reconstruction for Recurrent Head and Neck Cancers
 
Academic Achievements
 
  • Editorial Board Member of over 10 Chinese & international journals (including Chinese Journal of Otorhinolaryngology-Head and Neck Surgery)
  • Author of over 200 peer-reviewed publications
  • Editor/Translator/Contributor to 23 textbooks
 
Honors & Awards
 
  • Distinguished Young Expert of Jiangsu Province
  • Overseas High-Level Talent of Jiangsu Province
  • Jiangsu Provincial “Double Innovation” Talent & Team Leader
  • Distinguished Medical Expert of Jiangsu Province
  • Chief Expert in Head and Neck Oncology (Jiangsu Province)
  • Beijing “New Century Hundred-Thousand-Ten Thousand Talents” Program Recipient
  • Beijing Municipal Health System “Ten-Hundred-Thousand” Talent
  • Distinguished Physician Award, Chinese Medical Association of Otolaryngologists
  • Outstanding Young Investigator Award, Chinese Society of Otorhinolaryngology-Head and Neck Surgery
 
Professional Memberships
 
  • Executive Director (China), International Federation of Head and Neck Oncology Societies (IFHNOS)
  • Standing Committee Member, Asia Pacific Thyroid Surgery Association (APTS)
  • Committee Member, Laryngeal Cancer Quality Control Board, National Cancer Center
  • Standing Committee Member, Chinese Medical Association of Otolaryngologists
  • Standing Committee Member, Chinese Anti-Cancer Association Head and Neck Oncology Committee
  • Standing Committee Member, China International Exchange and Promotion Association for Medical and Healthcare (Otolaryngology Branch)
  • Chairman, Chinese Association of Non-Public Medical Institutions (Otolaryngology-Head and Neck Surgery Branch)
  • Standing Committee Member, Jiangsu Medical Association (Otolaryngology-Head and Neck Surgery Branch)
  • Vice President, Jiangsu Medical Association of Otolaryngologists

Xia Yin
Head of the Department of Otolaryngology
Chief Physician

Education: Doctor of Medicine, Postdoctoral

Department: Otolaryngology-Head and Neck Surgery

Specialties: Proficient in the diagnosis and treatment of difficult and complex ear diseases such as lateral skull base tumors, deafness, facial paralysis, and dizziness. Accumulated rich clinical experience in various lateral skull base tumors (acoustic neuroma, jugular paraganglioma, external and middle ear cancer, benign tumors of the temporal bone, petrous bone cholesteatoma, etc.), deafness (unilateral deafness-BAHA, bilateral deafness-cochlear implants, chronic otitis media-mastoidectomy and hearing reconstruction surgery, etc.), facial paralysis (facial nerve decompression surgery, facial nerve anastomosis, etc.), dizziness (Meniere’s disease-semicircular canal plugging surgery, endolymphatic sac decompression surgery), and surgical treatment of cerebrospinal fluid leaks.

Main Experiences:
Head of the Department of Otolaryngology
Former Director of Otolaryngology-Head and Neck Surgery, Beijing Tiantan Hospital, Capital Medical University

Doctor of Medicine, Postdoctoral, Visiting Scholar at the HOUSE Research Institute, University of Southern California, USA, Visiting Scholar at the FISCH Ear Center, University of Zurich, Switzerland

Academic Positions:
Chief Expert at the Vertigo Clinical Diagnosis and Treatment Center, Capital Medical University
Tutor at the FISCH International Skull Base Surgery Course
Vice President of the Chinese Eugenics Science Association
Standing Committee Member and Secretary-General of the Skull Base Surgery Branch of the China International Health Exchange Promotion Association
Member of the Otolaryngology-Head and Neck Surgery Physicians Branch of the Chinese Medical Doctor Association
Standing Committee Member of the China International Health Exchange Promotion Association (Otorhinolaryngology, Artificial Hearing, and Otology Branch)
Standing Committee Member of the Otolaryngology-Head and Neck Surgery Branch of the Beijing Medical Association
Standing Committee Member of the Otolaryngology-Head and Neck Surgery Physicians Branch of the Beijing Medical Doctor Association
Deputy Editor of the Chinese Journal of Clinical Doctors, Editorial Board Member of the Chinese Journal of Otolaryngology-Head and Neck Surgery, etc.

Professional Expertise:
Proficient in the diagnosis and treatment of difficult and complex ear diseases such as lateral skull base tumors, deafness, facial paralysis, and dizziness. Accumulated rich clinical experience in various lateral skull base tumors (acoustic neuroma, jugular paraganglioma, external and middle ear cancer, benign tumors of the temporal bone, petrous bone cholesteatoma, etc.), deafness (unilateral deafness-BAHA, bilateral deafness-cochlear implants, chronic otitis media-mastoidectomy and hearing reconstruction surgery, etc.), facial paralysis (facial nerve decompression surgery, facial nerve anastomosis, etc.), dizziness (Meniere’s disease-semicircular canal plugging surgery, endolymphatic sac decompression surgery), and surgical treatment of cerebrospinal fluid leaks.

Research and Honors:
Published over 60 papers, authored and translated 9 monographs, co-edited and co-translated 6 monographs; led more than 10 provincial and ministerial-level projects, received 2 provincial-level awards.

Lu Yuanyuan
Chief of Department of Otolaryngology Head and Neck Surgery, Director of Snoring Center, Director of Adenoid and Tonsil Center

Education: Master of Medicine

Department: Otolaryngology Head and Neck Surgery

Specialties: Proficient in the diagnosis and treatment of obstructive sleep apnea syndrome in children and adults, pediatric otolaryngological diseases, and pharyngeal and vocal cord diseases; pediatric and adult pharyngolaryngeal microsurgery under suspension laryngoscopy, CO2 laser pharyngolaryngeal tumor resection surgery, hyoid joint reduction surgery, comprehensive treatment of laryngeal papilloma, etc. Regularly conducts diagnosis and treatment of various specialized diseases.

Main Experiences:
Chief of Department of Otolaryngology Head and Neck Surgery, Director of Snoring Center, Director of Adenoid and Tonsil Center

Master of Medicine, Chief Physician
Specialties:
Proficient in the diagnosis and treatment of obstructive sleep apnea syndrome in children and adults, pediatric otolaryngological diseases, and pharyngeal and vocal cord diseases; pediatric and adult pharyngolaryngeal microsurgery under suspension laryngoscopy, CO2 laser pharyngolaryngeal tumor resection surgery, hyoid joint reduction surgery, comprehensive treatment of laryngeal papilloma, etc. Regularly conducts diagnosis and treatment of various specialized diseases.

Committee Member:
Member of the Sleep Medicine Professional Committee of the Chinese Medical Doctor Association Otolaryngology Branch,
Member of the Otolaryngology Head and Neck Surgery Professional Committee of the Chinese Non-Public Medical Institutions Association,
Member of the Pharyngeal and Vocal Cord Group of the Otolaryngology-Head and Neck Surgery Branch of the Jiangsu Medical Association,
Young Member of the Otolaryngology Head and Neck Surgery Physician Branch and Member of the Sleep Medicine Professional Committee of the Jiangsu Medical Doctor Association,
Member of the Precise Diagnosis and Treatment Professional Committee of Pharyngeal Head and Neck Tumors of the Jiangsu Research Hospital Association,
Member of the Jiangsu Double Innovation Talent Team,
Member of the Precision Medicine Association across the Taiwan Straits-HPV Infection Disease Professional Committee

Honors:
Won multiple national and Jiangsu Province Young Physician Surgical Video Competition awards for refined tonsillectomy and adenoidectomy in children.

Gong Danchun
Chief Physician and Deputy Director of Otolaryngology-Head and Neck Surgery

Education: Master’s degree from Nanjing Medical University, currently pursuing a doctoral degree

Department: Otolaryngology-Head and Neck Surgery

Specialties: Proficient in minimally invasive and endoscopic surgery for thyroid (parathyroid) tumors, endoscopic minimally invasive and radical surgery for malignant tumors in the head and neck region, salvage surgery after radiotherapy for nasopharyngeal carcinoma, surgical treatment for snoring, microsurgery for voice disorders, functional endoscopic sinus surgery. Regularly diagnose and treat various specialized diseases.

Professional Experience:
Chief Physician and Deputy Director of Otolaryngology-Head and Neck Surgery

Doctor of Medicine (currently pursuing)

Specialties: Proficient in minimally invasive and endoscopic surgery for thyroid (parathyroid) tumors, endoscopic minimally invasive and radical surgery for malignant tumors in the head and neck region, salvage surgery after radiotherapy for nasopharyngeal carcinoma, surgical treatment for snoring, microsurgery for voice disorders, functional endoscopic sinus surgery. Regularly diagnose and treat various specialized diseases.

Memberships:
Member of the Skull Base Surgery Branch of the China International Health Exchange Promotion Association,

Member of the Otolaryngology-Head and Neck Surgery Branch of the Jiangsu Medical Association,

Deputy Head and Neck Group Leader of the Otolaryngology Department of the Jiangsu Physician Association,

Executive Committee Member of the Precision Diagnosis and Treatment Professional Committee for Head and Neck Tumors and Member of the Otolaryngology Endoscopy Professional Committee of the Jiangsu Research Hospital Association,

Young Member of the Thyroid Cancer Professional Committee of the Jiangsu Anti-Cancer Association,

Member of the Otolaryngology-Head and Neck Surgery Branch of the Nanjing Medical Association

Honors:
Recipient of multiple awards in national young physician surgical video competitions and more.

Zhang Yijuan
Chief of Department, Chief Physician

Education: Master’s degree from Nanjing Medical University

Department: Department of Otolaryngology Head and Neck Surgery

Specialties: Specializes in the diagnosis and treatment of allergic rhinitis, chronic rhinitis, and sinusitis; endoscopic surgery for intractable nasal bleeding; nasal polyps, deviated nasal septum, skull base surgery, oculonasal surgery (including optic nerve decompression, nasolacrimal duct anastomosis, orbital decompression), surgical and comprehensive treatment of benign and malignant tumors of the nasal cavity and sinuses. Regularly conducts diagnosis and treatment of various specialized diseases.

Dr. Wu Xuejie
 
Title
 
Vice President, Director of Urology, PhD
 
Education
 
  • PhD in Urology, Xiangya School of Medicine, Central South University
  • Visiting Scholar, UCLA Medical Center, University of California, USA
  • Visiting Fellow, Mayo Clinic (USA), Germany and ICET, Netherlands
  • Visiting Fellow, University of Southern California (USC), under the National Urology “Elite Program”
 
Department
 
Department of Urology
 
Clinical Specialties
 
  • Specializes in minimally invasive endoscopic surgery for urinary system diseases
  • Performed more than 1,300 minimally invasive surgeries for benign prostatic hyperplasia, including TURP, plasmakinetic enucleation, laser vaporization and laser enucleation
  • Performed more than 1,000 minimally invasive endoscopic surgeries for urinary calculi
  • Expert in laparoscopic adrenal tumor resection, laparoscopic deroofing of renal cysts, radical nephrectomy, nephron-sparing partial nephrectomy and total nephroureterectomy
  • Proficient in surgical treatment for renal cell carcinoma with vena cava tumor thrombus
  • Skilled in en bloc laser resection of bladder tumors, radical cystectomy for bladder cancer and radical prostatectomy for prostate cancer
 
Academic Memberships
 
  • Standing Committee Member, Medical Shock Wave Committee, Chinese Research Hospital Association; Vice Chairman, Andrology Group
  • Member, Urology Committee, Chinese Research Hospital Association
  • Member, Endoscopic Surgery Branch, China International Exchange and Promotion Association for Medical and Healthcare
  • Editorial Board Member, Journal of Urology (Electronic Edition), Chinese Journal of Medical Frontier (Electronic Edition), China Medical Pharmaceutical Science and Technology
  • Review Expert, Beijing Natural Science Foundation
 
Publications & Awards
 
  • Published more than 50 papers in professional journals and co-authored 10 monographs
  • Presided over 2 projects of the Chinese People’s Armed Police Force and 1 Wu Jieping Medical Foundation project
  • Participated in 1 National High-Tech Research and Development Program (863 Program) and 2 National Natural Science Foundation of China projects
  • Received 1 Second Prize of National Science and Technology Progress, 1 Third Prize of Chinese Medical Science and Technology, 1 First Prize of Huaxia High-Tech Industry Innovation, and 6 Science and Technology Progress & Medical Achievement Awards of the Chinese People’s Armed Police Force
 
Honors
 
  • Outstanding Doctoral Student, Central South University
  • Advanced Individual by the Four General Headquarters of the Chinese People’s Liberation Army
  • Awarded one Second-Class Merit and one Third-Class Merit
  • Recipient of Post Allowance for Outstanding Technical Personnel of the Chinese People’s Liberation Army
Dr. Shan Yuxi
 
Title
 
Famous Medical Studio, PhD Supervisor
 
Department
 
Department of Urology
 
Professional Experience
 
  • Recipient of Special Government Allowance granted by the State Council
  • Former Director of Department of Urology, The Second Affiliated Hospital of Soochow University
 
Clinical Specialties
 
  • Treated more than 6,000 patients with benign prostatic hyperplasia, including over 1,500 cases treated with green laser vaporization.
  • Possesses solid professional foundation and surgical skills in urology, capable of managing complicated and difficult cases.
  • Long committed to clinical research and application of minimally invasive urological techniques.
  • Specializes in minimally invasive treatment of benign prostatic hyperplasia, renal and ureteral calculi, and genitourinary tumors.
  • Profound expertise in basic and clinical research on renal tumor, bladder tumor, prostate cancer, male sexual dysfunction and infertility.
  • Extensive experience in radical nephrectomy, radical nephroureterectomy, radical cystectomy with orthotopic ileal neobladder and other related surgeries.
 
Professional Memberships
 
  • Vice Chairman of Jiangsu Andrology Association & Member of Urology Committee, Chinese Medical Association
  • Chairman of Suzhou Andrology Association & Vice Chairman of Suzhou Urology Association
 
Awards & Honors
 
  • Received 13 provincial and ministerial Science and Technology Progress Awards, including 2 second prizes, 2 third prizes, and 1 third prize from Provincial Department of Education.
  • Awarded 4 fourth prizes of Science and Technology Progress by the Chinese People’s Liberation Army.
  • Won 1 second prize of New Medical Technology from Jiangsu Provincial Health Department, 1 Research Award from Suzhou Association for Science and Technology, and 2 third prizes of Science and Technology Progress from Suzhou Municipal Government in recent 5 years.
  • Received 2 second prizes for Excellent Papers from Suzhou Municipal Government.
  • Co-authored 3 monographs and served as associate editor of 1 monograph.
  • Rated Excellent in Annual Assessment for 8 consecutive years from 1997 to 2004.
  • Awarded Advanced Worker of Suzhou Health System and granted Third-Class Merit twice in 2001 and 2004.
  • Honored as Outstanding Party Member of Soochow University in 2005 and Model Worker of Suzhou in 2006.
 
Pioneering Practices
 
  • First to introduce transurethral resection of prostate in Suzhou and perform transurethral electrovaporization resection of prostate for benign prostatic hyperplasia.
  • First to introduce green laser system (photoselective vaporization of the prostate) in Jiangsu Province, providing a new treatment option for patients with benign prostatic hyperplasia.
  • Applied the 3rd generation EMS lithotripsy and stone removal system in East China for minimally invasive treatment of urinary calculi.
  • First to perform laparoscopic ureterolithotomy, high ligation of spermatic vein, orchiopexy for cryptorchidism and radical prostatectomy in Suzhou.
Dr. Zhou Yun
 
Title
 
Famous Medical Studio, Chief Physician, Professor, PhD Supervisor
 
Education
 
MD, PhD Supervisor
 
Department
 
Department of Urology
 
Professional Experience
 
  • MD, Professor, PhD Supervisor in Clinical Medicine
  • Director, Suzhou Famous Medical Studio of Pediatric Urology (Suzhou BenQ Hospital)
  • Chief Physician, Department of Urology, Children’s Hospital of Soochow University
 
Clinical Specialties
 
  • Specializes in diagnosis and treatment of congenital urinary system malformations, disorders of sex development, complicated urinary tract infections, and urolithiasis in children
  • Provides prenatal counseling for fetal urinary system developmental defects
 
Research Achievements
 
  • Undertaken 4 General Programs of the National Natural Science Foundation of China
  • Presided over 1 Jiangsu Provincial Special Program of Clinical Medical Science – Key Project of New Clinical Diagnostic Technology and 6 municipal and departmental research projects
  • Granted 5 National Utility Model Patents
  • Received 2 provincial and ministerial Science and Technology Progress Awards and 3 municipal Science and Technology Progress Awards
  • Published more than 60 medical academic papers, including 11 indexed in SCI
  • Co-authored 4 medical monographs
 
Professional Memberships
 
  • Member, Pediatric Group, Urology Branch, Chinese Medical Association
  • Member, Pediatric Surgery Branch, Chinese Medical Doctor Association
  • Member, Urology Committee, Suzhou Medical Association
  • Vice Chairman, Pediatrics Committee, Suzhou Association of Integrated Traditional Chinese and Western Medicine

Loujizhuang

Director of the Nephrology Department, Chief Physician, Master’s Supervisor

Department: Nephrology

Specialties: Engaged in clinical work related to kidney diseases for nearly 40 years, has been treating a large number of difficult and critically ill kidney disease patients at the forefront of clinical practice, accumulated rich clinical experience, and is skilled in the clinical application of blood purification technology.

Main Experiences:
Engaged in clinical work related to kidney diseases for nearly 40 years, has been treating a large number of difficult and critically ill kidney disease patients at the forefront of clinical practice, accumulated rich clinical experience, and is skilled in the clinical application of blood purification technology. Published over 40 papers in core and SCI journals.

Social Honors:
Director of Provincial Training Base for Blood Purification Technology

Chairman of the Quality Control Committee for Blood Purification in Nanjing

Leader of the Expert Group for Prevention and Control of COVID-19 in the Blood Dialysis Center in Nanjing

Honorary Chairman of the Nephrology Branch of the Nanjing Society of Chinese Medical Association

Vice Chairman of the Blood Purification Center Management Branch of the Hospital Society of Jiangsu Province

Vice Chairman of the Nephrology Branch of the Integrative Medicine Society of Jiangsu Province

Vice Chairman of the Kidney Disease Rehabilitation Professional Committee of the Rehabilitation Medicine Society of Jiangsu Province

Standing Committee Member of the 7th, 8th, and 9th Nephrology Branch of the Chinese Medical Association in Jiangsu Province

Standing Committee Member of the Nephrology Branch of the Jiangsu Provincial Medical Association

Member of the Quality Control Committee for Kidney Diseases in Jiangsu Province

Member of the Nephrology Collaboration Group of Six Provinces and One City in East China

National Committee Member of the Blood Purification Branch of the Research Society

Gao Zhanhui 
Chief Physician, Deputy Director of Nephrology, Director of Blood Purification Center

Education: Doctor of Medicine

Department: Nephrology

Specialties: Proficient in the diagnosis and treatment of difficult kidney diseases, including establishing and repairing difficult vascular access for hemodialysis patients, with a focus on the interventional treatment of complications of arteriovenous fistula, and precise treatment of renal bone disease

Brief Introduction:
Doctor of Medicine, Chief Physician, Master’s Supervisor

Deputy Director of Nephrology at Nanjing Mingji Hospital, Director of Blood Purification Center

Professional Memberships:
Committee Member of the Nephrology Branch of Jiangsu Medical Association
Committee Member of the Geriatric Nephrology Branch of Jiangsu Medical Association
Committee Member of the Nephrology Branch of Jiangsu Physician Association
Committee Member of the Toxicology Branch of Nanjing Medical Association
Standing Committee Member of the Nephrology Branch of Jiangsu Immunology Association
Committee Member of the Blood Purification Society of China Innovative Hospital Association
Committee Member of the Geriatric Nephrology Branch of Jiangsu Physician Association
Committee Member of the Blood Purification Branch of Jiangsu Hospital Management Association
Member of the Vascular Access Expert Group of the Blood Purification Branch of China Hospital Association
Committee Member of the Vascular Access Branch of the Non-Public Hospital Blood Purification Association

Technical Expertise:
Engaged in nephrology and blood purification for over 20 years, specializing in difficult vascular access techniques for hemodialysis patients through training at various blood purification centers in China.

Proficient in the diagnosis and treatment of difficult kidney diseases, including establishing and repairing difficult vascular access for hemodialysis patients, with a focus on the interventional treatment of complications of arteriovenous fistula, and precise treatment of renal bone disease

Research:
Participated in and led 4 national and provincial-level projects
Published over 20 SCI and core journal articles
Received two second prizes for the introduction of new medical technologies in Jiangsu Province as the first author.

Ji Daxi
Chief Physician, Professor, Doctoral Supervisor, Postdoctoral Mentor
Current Position: Honorary President of Nanjing Mingji Hospital, Specially Appointed Chief Expert in Nephrology


Military Rank/Benefits: Level 3 Technical Officer in the military, Expert receiving special government allowance from the State Council (approved in 1993)
Education Background: Graduated from the Military Medical Training Team of Nanjing General Hospital of Nanjing Military Region
Overseas Training:
In 1991, studied at the Kidney Research Institute of Tokyo Women’s Medical University in Japan
In 2001, furthered studies at the University of California, Seattle, USA
Previous Military Position:
Former Deputy Chief Physician and Chief Physician of the Nephrology Department at Nanjing General Hospital of Nanjing Military Region (Military Kidney Disease Research Institute), core expert of the National Clinical Medical Research Center for Kidney Diseases.
Career at Nanjing Mingji Hospital:
Served as President of Nanjing Mingji Hospital, currently appointed as Honorary President, concurrently serving as Specially Appointed Chief Expert in Nephrology, overseeing departmental discipline construction, consultation for difficult and critical cases, and leading technology at the Blood Purification Center.
Academic Positions at Universities:
Professor at Nanjing University School of Medicine, Doctoral Supervisor, Postdoctoral Mentor; Postdoctoral Mentor at Nanjing Medical University.

Dr. Zhi Min
 
Title
 
Director of Nephrology Department, MD
 
Education
 
  • Bachelor of Clinical Medicine, Southeast University
  • Master’s Degree and MD, Xinjiang Medical University
 
Department
 
Department of Nephrology
 
Professional Experience
 
  • Chief Physician of Nephrology, The Fifth Affiliated Hospital of Xinjiang Medical University
 
Clinical Specialties
 
  • Diagnosis and treatment of acute and chronic glomerulonephritis, nephrotic syndrome, acute kidney injury, chronic renal failure and secondary kidney diseases.
  • Specializes in formulating individualized hemodialysis and peritoneal dialysis programs.
  • Rich clinical experience in the diagnosis and treatment of primary and secondary kidney diseases, including membranous nephropathy, diabetic nephropathy, gout and its renal damage, lupus nephritis, vasculitis-related renal damage, Sjögren’s syndrome and its renal damage.
 
Publications
 
  • Published more than 20 papers in core journals
  • Co-authored one book
 
Professional Memberships
 
  • Member, Blood Purification Branch, Suzhou Medical Association
  • Member, Integrated Traditional Chinese and Western Medicine Nephrology Branch, Suzhou Medical Association
  • Member, Nephrology Rehabilitation Branch, Suzhou Medical Association
  • Member, Youth Group, Nephrology Branch, Xinjiang Medical Association
 
Awards & Honors
 
  • Awarded the titles of Advanced Worker and Excellent Teacher many times
  • Third Prize of Science and Technology Progress Award of Xinjiang Uygur Autonomous Region
  • Member of the Expert Database for Medical Malpractice Identification of Xinjiang Uygur Autonomous Region
Dr. Chen Jianfeng
 
Title
 
Deputy Director of General Surgery
 
Director of Hepatobiliary & Pancreatic Surgery
 
Chief Physician
 
Medical Postdoctoral Fellow
 
Professional Experience
 
  • Mentored by Academician Dong Jiahong
  • Visiting Scholar, AKH General Hospital, Vienna, Austria
 
Clinical Specialties
 
  • Nearly 30 years of experience in general surgery and hepatobiliary surgery
  • Specializes in the diagnosis and treatment of common general surgery and hepatobiliary diseases
  • Expert in surgical and comprehensive treatment for primary and secondary liver cancer, cholangiocarcinoma, ampullary tumors, cholelithiasis, pancreatic tumors, and portal hypertension
  • Proficient in advanced surgical techniques including laparoscopic precise hepatectomy, right/left hemihepatectomy, combined endoscopic choledocholithotomy, hepatojejunostomy, pancreaticoduodenectomy, distal pancreatectomy, splenectomy, and radical resection of gastric and colorectal cancer
 
Research Achievements
 
  • Published over 30 academic papers, including 5 indexed in SCI
  • Presided over 1 project of the National Natural Science Foundation of China
  • Presided over 1 Shandong Provincial Science and Technology Plan Project
  • Presided over 1 Open Project of the Faculty of Chemistry, Qingdao University of Science and Technology
  • Presided over 1 China Postdoctoral Science Foundation Project
  • Granted 1 national invention patent
  • Chief editor of 2 monographs
 
Professional Memberships
 
  • Member, Portal Hypertension Group, General Surgery Committee of the Chinese People’s Liberation Army
  • Member, Chinese Society of Hepatology, Chinese Medical Association
  • Vice Chairman, Hepatobiliary Surgery Committee, Shandong Association of Integrated Traditional Chinese and Western Medicine
  • Member, Minimally Invasive Medicine Branch, Shandong Medical Association
  • Youth Member, Organ Transplantation Branch, Shandong Medical Association
  • Youth Member, Hepatobiliary Surgery Branch, Shandong Medical Doctor Association
  • Vice Chairman, Hepatopancreatobiliary Surgery Committee, Qingdao Association of Integrated Traditional Chinese and Western Medicine
  • Vice Chairman, Hepatopancreatobiliary Surgery Committee, Qingdao Gerontological Society
  • Vice Chairman, Hepatopancreatobiliary Surgery Branch, Qingdao Health Science and Technology Association
  • Member, General Surgery Branch, Qingdao Medical Association
  • Member, Organ Transplantation Branch, Qingdao Medical Association
  • Member, Liver Cancer Committee, Qingdao Anti-Cancer Association
Dr. Wu Haorong
 
Title
 
Chief Physician, PhD Supervisor
 
Senior General Surgery Expert
 
Education
 
  • Master’s Degree, Suzhou Medical College
 
Professional Experience
 
  • Sep. 1984 – Jun. 1987: Master’s student, Suzhou Medical College
  • Jul. 1987 – Nov. 1988: Department of General Surgery, The First Affiliated Hospital of Suzhou Medical College
  • Dec. 1988 – Present: Department of General Surgery, The Second Affiliated Hospital of Soochow University
  • 1991 – 1993: Research fellow, Louis Mouriers Hospital, Paris, France
  • 1997: Associate Professor, Master’s Supervisor, The Second Affiliated Hospital of Soochow University
  • 2001: Professor, PhD Supervisor, The Second Affiliated Hospital of Soochow University
 
Clinical Specialties
 
  • Extensive clinical experience in general surgery and skilled in treating complex and difficult cases
     
  • Unique advantages in diagnosis and treatment of general surgical diseases
     
  • Provincial leading level in laparoscopic minimally invasive surgery for gallstones, splenectomy, inguinal hernia repair, incisional hernia repair, radical gastrectomy, radical rectal cancer surgery and radical colon cancer surgery
     
  • Pioneered a series of advanced laparoscopic surgeries in China after returning from France in 1993, including laparoscopic cholecystectomy, splenectomy for acute diseases, subtotal thyroidectomy for thyroid adenoma and hyperthyroidism, hernia repair, radical resection of rectal cancer and gastric cancer
     
  • National advanced level in minimally invasive surgical techniques with high reputation across the country
     
 
Professional Affiliations
 
  • Recipient of Special Government Allowance granted by the State Council
  • Member, Asia Pacific Association of Endoscopic and Laparoscopic Surgeons
  • Vice President, French Association for Medical Innovation
  • Member, Jiangsu Provincial Surgical Committee, Chinese Medical Association
  • Director, Endoscopic Technology Training Base, Ministry of Health
  • Expert, General Surgery Endoscopic Technology Evaluation Committee, Ministry of Health
  • Former Deputy Leader, Laparoscopy Group, Jiangsu Medical Association
  • Chairman, Suzhou General Surgery Association
 
Awards & Research
 
  • First Prize, Science and Technology Progress Award, Jiangsu Provincial Commission of Science, Technology and Industry for National Defense (1999): Application of Laparoscopy in Abdominal Surgery
  • Second Prize, National Defense Science and Technology Progress Award (1999): Experimental and Clinical Research of Colorectal Cancer
  • Second Prize, National Defense Science and Technology Progress Award (2001): Radioimmunoguided Diagnosis of Tumors and Thrombotic Diseases
  • Third Prize, National Defense Science and Technology Progress Award (2003): Imaging Study of Breast Cancer and Lymph Node Metastasis
  • Project of Natural Science Foundation of Jiangsu Province (2005): IL-12 Gene Targeted Transfection of Kupffer Cells for the Treatment of Intrahepatic Micrometastasis of Hepatocellular Carcinoma
Dr. Wu Guoqiang
 
Title
 
Chief Physician, PhD
 
Director of General Surgery
 
Education
 
  • Bachelor of Clinical Medicine (6-year program), Third Military Medical University
  • Master of Surgery (Plastic Surgery), Fourth Military Medical University
  • Doctor of Surgery, Fourth Military Medical University
 
Professional Experience
 
  • Chief Physician, Department of General Surgery, Former General Hospital of Shenyang Military Command (now Northern Theater General Hospital)
  • Deputy Director & Chief Physician, Department of General Surgery, Northeast International Hospital
 
Clinical Specialties
 
  • Specializes in minimally invasive and comprehensive treatment of gastric, colorectal, morbid obesity, breast and hernia diseases
  • Profound expertise in standard radical mastectomy, breast-conserving surgery, breast reconstruction and abdominal wall hernia surgery
  • Proficient in laparoscopic surgery with extensive experience in perioperative management and nutritional support for critically ill patients
  • Expert in applying precision, minimally invasion, enhanced recovery after surgery (ERAS) and patient-centered care in clinical practice
 
Academic Achievements
 
  • Published over 20 papers in core journals as first author, including 3 SCI and 2 EI indexed articles
  • Co-authored 4 monographs
  • Granted one national patent and one provincial natural science foundation project
  • Received one second-class and one third-class Military Science and Technology Progress Award
 
Professional Memberships
 
  • Member, Medical Association of Suzhou High-tech Zone
  • Member, Gastrointestinal Group, General Surgery Committee of Suzhou Medical Association
  • Member, Metabolic & Bariatric Group, General Surgery Committee of Suzhou Medical Association
  • Member, Obesity & Diabetes Surgery Group, Jiangsu Medical Doctor Association
  • Member, Anorectal Surgery Branch, Chinese Medical Doctor Association
  • Member, American Pancreatic Association

Dr. Ying Xiao
Director of Obstetrics and Gynecology Department, Discipline Leader, Professor, Chief Physician, Doctoral Supervisor

Education: Postdoctoral fellow at Yale University and Harvard Medical School in the United States

Department: Gynecology

Specialties: Engaged in clinical work in obstetrics and gynecology for over 40 years, specializing in gynecological endoscopic surgery, cervical insufficiency, female pelvic organ prolapse diseases, stress urinary incontinence, high-risk obstetrics, infertility, etc. Expertise in female reproductive tract reconstruction (congenital absence of vagina, asymmetry of labia minora, hypertrophy, vaginal relaxation, hymen repair), and gynecological tumors.

Main Experiences:
– Vice President of East Hospital, Second Affiliated Hospital of Nanjing Medical University
– Director of Obstetrics and Gynecology Department, Second Affiliated Hospital of Nanjing Medical University
– Director of Obstetrics and Gynecology Department, Affiliated Yifu Hospital of Nanjing Medical University
– Director of Obstetrics and Gynecology Department, Eighth People’s Hospital of Shanghai
– Director of the National Health and Family Planning Commission’s Level Four Gynecological Endoscopic Surgery Training Base
– Participant in the 333 Project
– Key Talent of the Jiangsu Province Health Project
– Selected as a High-level Talent in the “Six Talent Peaks” of Jiangsu Province

Clinical Expertise:
Engaged in clinical work in obstetrics and gynecology for over 40 years, specializing in gynecological endoscopic surgery, cervical insufficiency, female pelvic organ prolapse diseases, stress urinary incontinence, high-risk obstetrics, infertility, female reproductive tract reconstruction, and gynecological tumors.

Since 2006, successfully organized 20 national-level continuing education programs on “Innovative Techniques in Gynecology,” demonstrating and promoting gynecological laparoscopic minimally invasive surgery and pelvic floor repair surgery. Over a thousand obstetricians and gynecologists from across the country have participated in these seminars. Renowned domestic and international experts have been invited to give academic lectures and surgical demonstrations, continuously enhancing the discipline’s level, academic influence, and technical standards, leading at the national and provincial levels. In February 2011, the Obstetrics and Gynecology Department of the Second Affiliated Hospital of Nanjing Medical University smoothly obtained the first batch of Level Four Gynecological Endoscopic Surgery Training Base designated by the National Health and Family Planning Commission, making outstanding contributions to the introduction and promotion of new gynecological laparoscopic technologies in Jiangsu Province.

Research:
While focusing on clinical work, Dr. Ying Xiao has accumulated over 10 national, provincial, and municipal research projects. In the past five years, she has led six projects, including research on medical and health technology development by the National Health and Family Planning Commission and clinical medicine special projects by the Jiangsu Provincial Department of Science and Technology. She has published over 100 academic papers in domestic and international journals, including more than 30 SCI papers, demonstrating excellent scientific research and project organization capabilities. She has been awarded the title of Outstanding Graduate Supervisor and Three-Educational Model at Nanjing Medical University multiple times.

Professional Affiliations:
– Member of the American Association of Gynecological Laparoscopy
– Vice President of the Science and Innovation in Plastic Surgery and Organ Reconstruction Branch of the Chinese Association of Plastic and Aesthetic Surgery
– Vice President of the Gynecological Association of the World Endoscopy Physicians Association
– Deputy Director of the Obstetrics and Gynecology Professional Committee of the National Health Commission’s Famous Doctors and Hospitals Development Promotion Professional Committee
– Deputy Director of the Obstetrics and Gynecology Professional Committee of the Jiangsu Province Medical Quality Control Center
– Chairman of the Pelvic Floor Integration Professional Committee of the Jiangsu Province Medical Association
– Chairman of the Second Session of the Obstetrics and Gynecology Tumor Branch of the Jiangsu Province Medical Association
– Deputy Group Leader of the Endocrinology Group of the Obstetrics and Gynecology Branch of the Jiangsu Province Medical Association
– Deputy Group Leader of the Endoscopy Group of the Obstetrics and Gynecology Branch of the Jiangsu Province Medical Association
– Deputy Group Leader of the Obstetrics and Gynecology Management Group of the Jiangsu Province Medical Association
– Deputy Director of the Tenth Obstetrics and Gynecology Branch Committee of the Jiangsu Province Medical Association
– Deputy Group Leader of the Gynecology Group of the Micro-invasive Medical Professional Committee of the Jiangsu Province Medical Association
– Chairman of the First Laparoscopy Group of Nanjing City
– Deputy Director of the Obstetrics and Gynecology Professional Committee of the Nanjing Medical Association
– Editorial Board Member of the Chinese Journal of Minimally Invasive Surgery, Chinese Journal of Modern Clinical Medicine, and Journal of Nanjing Medical University
– Editorial Board Member of the National Higher Medical Textbook: “Introduction to Human Pathology” Obstetrics and Gynecology section
– Chief Editor of the series “Key Points and Typical Cases in Modern Obstetrics and Gynecology Diagnosis and Treatment”
– Chief Editor of high-quality resources sharing courses and series textbooks in clinical medicine in higher education institutions
– Deputy Editor of the English version of the National Health and Family Planning Commission’s “Thirteenth Five-Year Plan” and the National Higher Medical Textbook Construction Research Association’s Medical Professional English version planning textbook “Obstetrics and Gynecology”

Song Hongjuan (Director of Obstetrics and Gynecology, Chief Physician, Master’s Supervisor)

Education: Doctorate

Department: Obstetrics and Gynecology

Specialties: Engaged in clinical work for 34 years, rich clinical experience, proficient in various gynecological oncology surgeries. Able to independently perform various gynecological oncological surgeries (extensive hysterectomy + pelvic lymph node dissection + ovarian transplantation), ovarian cancer debulking surgery, tubal reanastomosis, gynecological microsurgery, vaginal reconstruction surgery (colon vaginoplasty and skin flap vaginoplasty).

Main Experiences:
1. Educational Background:

– 2011.09-2012.06, Mayo Clinic, USA (Gynecology Dept)
– Major: Gynecological oncology surgical treatment, robotic surgery, laparoscopic and hysteroscopic surgery, surgical treatment of pelvic floor dysfunction

– 2006.09-2009.07, China Pharmaceutical University (Full-time)
– Major: Reproductive endocrinology, Degree: Doctorate

– 2000.09-2002.01, Nanjing Medical University (Full-time)
– Major: Obstetrics and Gynecology, Degree: Master’s

– 1985.09-1990.07, Xuzhou Medical University
– Major: Clinical Medicine, Degree: Bachelor’s

2. Work Experience:

– 2009.07-present, Xuzhou Maternal and Child Health Hospital, Director of Obstetrics and Gynecology/Ward, Chief Physician
– 2000.09-2009.07, Xuzhou Central Hospital, Deputy Chief Physician of Obstetrics and Gynecology, Deputy Director of Department
– 1990.07-2000.09, Second Affiliated Hospital of Xuzhou Medical University, Obstetrics and Gynecology Physician, Attending Physician

Clinical Expertise:
– Proficient in robotic surgery, assistant laparoscopic surgery, single-incision laparoscopic surgery, conventional laparoscopic surgery, hysteroscopic surgery, vaginal surgery, with extensive experience in the laparoscopic and hysteroscopic treatment of infertility, resulting in a high rate of natural pregnancy post-surgery.
– Proficient in vaginal surgeries (vaginal hysterectomy, anterior and posterior colporrhaphy) and abdominal surgeries; skilled in the treatment of female stress urinary incontinence with TVT, TRT, Sling surgery, InterStim surgery, pelvic floor suspension surgery, vaginal stump suspension surgery, and the treatment of overactive bladder (the first introduction of TRT and InterStim surgery in China and routine practice).
– Proficient in obstetric surgeries, forceps delivery, vacuum extraction, neonatal endotracheal intubation, with over thirty years of experience in handling a large number of critically ill emergency patients both in and out of the hospital, especially in the rescue of obstetric emergencies.

Academic Positions:
– Deputy Director of the Chinese Medical Association Publishing Committee
– Member of the Pelvic Floor Disease Diagnosis and Repair Group of the Hernia and Abdominal Wall Surgery Industry and Clinical Research Branch of the National Health Industry Enterprise Management Association
– Deputy Director of the Adolescent Medicine Professional Committee of the Jiangsu Medical Association
– Inspection expert for the “Maternal and Child Health China Walks into Jiangsu” activity of the Jiangsu Health and Family Planning Commission
– Medical damage identification expert in Jiangsu Province

Honors:
– One of the Six Talent Peaks Cultivation Objects in Jiangsu Province
– Key Talent Cultivation Object in Maternal and Child Health in Jiangsu Province
– 2017 Xuzhou March 8th Red Flag Bearer
– Xuzhou May 1st Women’s Model

1. Song Hongjuan, Analysis of Umbilical Cord Arterial Proteomics in Newborns, Xuzhou Medical New Technology Introduction Award, 2011, First Prize
2. Song Hongjuan, Clinical Research on Tumor-Free Technique in Laparoscopic Radical Surgery for Early Cervical Cancer, Jiangsu Medical New Technology Introduction Award, 2018, Second Prize
3. Song Hongjuan, Clinical Exploration of Combined Tumor-Free Technique in Laparoscopic Radical Surgery for Early Cervical Cancer, Xuzhou Medical New Technology Introduction Award, 2021, First Prize

Li Deming
Director of Obstetrics and Gynecology Department, Chief Physician

Main Experience:
Director of Obstetrics and Gynecology Department at Provincial Maternal and Child Health Hospital

Vice Chairman of Minimally Invasive Gynecology Committee of the Province

Vice Chairman of Reproductive and Family Planning Committee of the Province

Standing Committee Member of Provincial Obstetrics and Gynecology Committee

Vice President of Clinical Affairs at a Grade A Hospital

Specialties:
Engaged in clinical work in obstetrics and gynecology for over 30 years, always demanding strict standards of oneself, pursuing excellence in techniques, and showing compassion towards patients. Completed over 20,000 various obstetric and gynecological surgeries, accumulating rich clinical experience.

In obstetrics, experienced in normal delivery, managing difficult deliveries, and cesarean section surgeries, adept at handling various obstetric emergencies and complex high-risk obstetric surgeries. Strives for minimally invasive and aesthetically pleasing procedures while ensuring the safety of both mother and baby, meeting the aesthetic needs of the mothers.

In gynecology, adheres to the concept of minimally invasive surgery, excels in vaginal minimally invasive surgeries, capable of performing vaginal surgeries for common gynecological conditions such as uterine fibroids, ovarian tumors, ectopic pregnancies, and early-stage gynecological malignancies, offering advantages of scar-free, privacy protection, minimally invasive, safety, quick recovery, and cost-effectiveness. Leading in vaginal surgeries nationwide. Independently led a project funded by the Li Ka Shing Foundation with two million RMB to assist impoverished women, completing over a thousand vaginal gynecological surgeries during the foundation’s assistance period, receiving unanimous recognition and praise from a large number of patients. Conducted major surgeries for gynecological malignancies and has extensive clinical experience in repairing pelvic floor dysfunctions such as uterine prolapse, urinary incontinence, and improving the quality of life during menopause. Conducted intimate cosmetic surgeries to enhance women’s confidence in life and work.

Honors:
Advanced Individual in the National Medical and Health System

Hospital Special Contribution Award

Member of the Municipal People’s Congress

Member of the Provincial Political Consultative Conference

Dr. Lü Shengxiang
 
Title
 
MD, Master’s Supervisor
 
Education
 
PhD in Gastroenterology, Soochow University School of Medicine
 
Department
 
Department of Gastroenterology
 
Professional Experience
 
  • Deputy Chief Physician & Deputy Director, Huai’an Second People’s Hospital
  • Director of Department of Gastroenterology, Lianyungang First People’s Hospital
  • PhD Candidate in Gastroenterology, Soochow University School of Medicine
 
Clinical Specialties
 
  • Specialized in endoscopic diagnosis and treatment of gastrointestinal diseases
  • Proficient in:
    • Peroral endoscopic myotomy (POEM)
    • Submucosal tunneling endoscopic resection (STER)
    • Endoscopic full-thickness resection (EFTR)
    • Endoscopic purse-string suture (EPSS)
    • Sclerotherapy, tissue adhesive injection and ligation for esophagogastric variceal bleeding
    • Foreign body removal
    • Polypectomy
    • Esophageal and intestinal stricture dilation and stenting
    • Endoscopic submucosal dissection (ESD) for early gastrointestinal cancer
    • Endoscopic ultrasonography (EUS)
     
 
Professional Memberships
 
  • Member, Emergency First Aid Committee for Critical Gastrointestinal Bleeding, Jiangsu Research Hospital Association
  • Member, 10th Gastroenterology Branch, Jiangsu Medical Association
  • Member, Oncology Endoscopy Committee, Jiangsu Anti-Cancer Association
  • Member, Gastroenterology Branch, Jiangsu Medical Doctor Association
  • Member, Digestive Rehabilitation Committee, Jiangsu Rehabilitation Medical Association
  • Third-level Candidate, Phase 5 “333 High-level Talent Training Project”, Jiangsu Province (Young and Middle-aged Academic & Technical Leader)
  • Candidate, Phase 6 “521 Project”, Lianyungang City
  • Key Medical Talent & Member of Medical Innovation Team, “14th Five-Year” Huaguoshan Project for Strengthening Medicine through Science and Education, Lianyungang City
  • Recipient of multiple key R&D projects from Lianyungang High-tech Zone Bureau of Science and Technology and Lianyungang Medical New Technology Introduction Awards
 
Research Achievements
 
  • Published 5 SCI papers as first author or corresponding author, plus multiple Chinese core journal papers
  • Currently presiding over 1 hospital advanced technology project and 2 essential technology projects
Dr. Zhuge Yuzheng
 
Title
 
Famous Medical Studio
 
Chief Physician, MD, Professor, Master’s & PhD Supervisor
 
Department
 
Department of Gastroenterology
 
Professional Experience
 
Former Administrative Deputy Director of Department of Gastroenterology, Nanjing Gulou Hospital
 
Main Research Interests
 
  • Interventional diagnosis and treatment of liver cirrhosis with portal hypertension and hepatic vascular diseases
  • Specializes in transjugular intrahepatic portosystemic shunt (TIPSS) and percutaneous transhepatic variceal embolization (PTVE) for the prevention and treatment of esophagogastric variceal bleeding
 
Clinical Specialties
 
  • Successfully performed thousands of cases of transarterial chemoembolization (TACE) for patients with hepatocellular carcinoma
  • Other interventional procedures:
    • Budd‑Chiari syndrome
    • Biliary and gastrointestinal obstruction
    • Peripheral vascular occlusion
    • Partial splenic embolization
    • Angiography and interventional therapy for emergency gastrointestinal bleeding
     
  • Proficient in various ultrasound‑guided percutaneous puncture drainage and liver biopsy techniques
  • Rich clinical experience in the diagnosis and treatment of liver diseases
 
Professional Memberships
 
  • Leader, Digestive Vascular Diseases Group, Chinese Society of Gastroenterology, Chinese Medical Association
  • Member, Hemorrhage Group, Chinese Society of Emergency Medicine, Chinese Medical Association
  • Member, Drug-Induced Liver Disease Group, Chinese Society of Hepatology, Chinese Medical Association
  • Deputy Leader, Digestive Expert Group, Interventional Committee, Chinese Medical Doctor Association
  • Member, Hepatic Oncology Committee, Chinese Anti-Cancer Association
  • Vice Chairman, Gastroenterology Branch, Jiangsu Medical Association
  • Vice Chairman, Hepatology Branch, Jiangsu Medical Association
  • Editorial Board Member:
    • Chinese Journal of Digestive Endoscopy
    • Chinese Journal of Hepatology
    • Journal of Practical Hepatology
    • Hepatology
    • World Chinese Journal of Digestology
     
 
Awards & Research Achievements
 
  • Presided over many national, provincial and municipal research projects
  • Published more than 140 academic papers
  • Received Chinese Medical Science and Technology Award
  • Received First Prize of Jiangsu Medical Science and Technology Award
  • Awarded multiple Medical New Technology Introduction Awards of Jiangsu Province and Nanjing City

Gu Kaihua
Associate Chief Physician

Education: Master’s degree from the Military Medical College, PLA General Hospital (301)

Department: Gastroenterology
Professional Experience:
Associate Chief Physician of Gastroenterology, Nanjing Mingji Hospital
Associate Chief Physician of Gastroenterology, Suzhou Municipal Hospital (North Branch)
Associate Chief Physician of Gastroenterology, Nantong Ruici Hospital
Attending Physician of Gastroenterology, PLA General Hospital (309)

Specialties:
Reflux esophagitis, peptic ulcer disease, chronic gastritis, functional gastrointestinal disorders, acute pancreatitis, drug-induced liver disease, cirrhosis, gastrointestinal tumors

Memberships:
Member of the Chinese Society of Gastroenterology

Honors:
Received the PLA Medical Science and Technology Progress Award Third Prize twice

Wang Cheng
Director of Respiratory Department, Chief Physician, Ph.D.

Education: Ph.D. in Geriatric Respiratory Medicine, The First Affiliated Hospital of Anhui Medical University

Department: Department of Respiratory and Critical Care Medicine

Specialties: Expertise in: 1. Diagnosis and treatment of chronic cough; 2. Pulmonary nodules; 3. Standardized diagnosis and treatment of bronchial asthma and chronic obstructive pulmonary disease; 4. Early diagnosis and treatment of lung cancer; 5. Precision diagnosis and treatment of pulmonary infections

Title:
Chief Physician

Position:
Director of Respiratory Medicine

Main Experience:
Director and Chief Physician of Respiratory and Critical Care Medicine, Nanjing Mingji Hospital

Ph.D. in Geriatric Respiratory Medicine, The First Affiliated Hospital of Anhui Medical University

Respiratory Medicine training at Shanghai Pulmonary Hospital

Clinical Expertise:
Expertise in: 1. Diagnosis and treatment of chronic cough; 2. Pulmonary nodules; 3. Standardized diagnosis and treatment of bronchial asthma and chronic obstructive pulmonary disease; 4. Early diagnosis and treatment of lung cancer; 5. Precision diagnosis and treatment of pulmonary infections

Honors:
Star of Medical Ethics in Jiangsu Province and Advanced Individual in Epidemic Prevention in Nanjing City

Dr. Xu Xingxiang
 
Title
 
Department Director, Postdoctoral Fellow, Professor, Chief Physician
 
PhD Supervisor & Postdoctoral Supervisor
 
Education
 
  • Postdoctoral Fellow, Peking Union Medical College Hospital
  • Visiting Scholar, Harvard Medical School
  • PhD, Professor, Chief Physician
  • PhD Supervisor & Postdoctoral Supervisor
  • Honorary Director of Respiratory Department & Director of Lung Cancer Center, Northern Jiangsu People’s Hospital
 
Department
 
Department of Respiratory Medicine
 
Professional Experience
 
  • Graduated from the Third Military Medical University
  • Postdoctoral Fellow, Peking Union Medical College Hospital
  • Visiting Scholar, Harvard Medical School
  • PhD, Professor, Chief Physician
  • PhD Supervisor & Postdoctoral Supervisor
  • Honorary Director of Respiratory Department & Director of Lung Cancer Center, Northern Jiangsu People’s Hospital
 
Clinical Specialties
 
  • Long-term basic and clinical research on lung cancer, ARDS and interstitial lung disease.
  • Proficient in the diagnosis and treatment of common respiratory diseases, with extensive experience in the diagnosis and treatment of complicated respiratory disorders.
 
Professional Memberships
 
  • Reviewer of China Postdoctoral Science Foundation
  • Vice Chairman, COPD Rehabilitation Branch, Respiratory Disease Rehabilitation Committee, Chinese Medical Education Association
  • Former National Member, Lung Cancer Group, Respiratory Society, Chinese Medical Association
  • Member, 1st Data Committee, Chinese Society of Clinical Oncology (CSCO)
  • Standing Member, 1st Sleep Medicine Committee, Chinese Research Hospital Association
  • Member, 1st Respiratory Endoscopy Branch, Interventional Oncology Committee, Chinese Anti-Cancer Association
  • Member, 1st Chest Cancer Branch, China International Exchange and Promotion Association for Medical and Healthcare
  • Member, 1st Critical Care Expert Committee, Emergency Branch, Chinese Medical Association
  • Member, 1st Critical Care Medicine Collaborative Committee, East China Region
  • Standing Member, Jiangsu Respiratory Committee
  • Vice Leader, Lung Cancer Group, Jiangsu Respiratory Society
  • Standing Member, Respiratory Branch, Jiangsu Medical Doctor Association
  • Member, Sleep Disorders Branch, Jiangsu Medical Doctor Association
  • Leader, Tobacco Group, Jiangsu Respiratory Society
  • Elected Famous Doctor of Jiangsu Province, Northern Jiangsu Craftsman & Chief Expert
  • Editorial Board Member, Chinese Journal of Lung Diseases
  • Reviewer, Journal of Chinese Cell Biology
 
Awards & Research Achievements
 
  • Undertaken more than 10 projects including sub-projects of the National 973 Program, National and Provincial Natural Science Foundations, Clinical Medical Science Special Projects, and Jiangsu “Six Talent Peaks” Program.
  • Received:
    • Second Prize of PLA Science and Technology Progress Award
    • Third Prize of Science and Technology Progress Award in Shandong Province, Sichuan Province and Tai’an City respectively
    • Second Prize of Jiangsu New Technology Introduction Award
    • Second and Third Prizes of Yangzhou Science and Technology Progress Award
    • Three First Prizes of New Technology Introduction
    • Four national patents including one invention patent
     
  • Compiled 7 guidelines and consensuses, edited 1 monograph, contributed to 3 monographs including Xiehe Respiratory Medicine.
  • Published more than 60 academic papers, including more than 10 SCI papers, 5 of which have an impact factor above 10, with the highest IF of 38.7.

Cai Jiankang
Chief Physician, Associate Professor

Department: Respiratory and Critical Care Medicine

Specialties: Engaged in clinical, teaching, and research work for 39 years, with rich clinical experience in the diagnosis and treatment of critical and difficult cases of respiratory system diseases.

Main Experiences:
– Studied medical specialty at Nantong Medical College from August 1979 to August 1984, obtaining a bachelor’s degree.
– Radiologist and assistant at the Second Affiliated Hospital of Nanjing Medical University from August 1984 to December 1987.
– Physician and assistant in the Respiratory Department of the Second Affiliated Hospital of Nanjing Medical University from December 1987 to March 1993.
– Senior advanced training in respiratory medicine at Gulou Hospital in Nanjing from May 1989 to May 1990.
– Attended graduate courses at Nanjing Medical University from May 1999 to June 2001.
– Deputy Chief Physician in the Respiratory Department of the Second Affiliated Hospital of Nanjing Medical University from October 1999 to 2005.
– Associate Professor and Deputy Director of Internal Medicine at the Second Affiliated Hospital of Nanjing Medical University from 2004.
– Chief Physician in the Respiratory Department of the Second Affiliated Hospital of Nanjing Medical University since 2005, also serving as a part-time professor at Nantong University School of Medicine.
– Attained the title of Chief Physician at the Third Affiliated Hospital of Nanjing Medical University in 2012.
– Specially appointed expert at the Affiliated Yifu Hospital of Nanjing Medical University since 2016.

Professional Expertise:
Engaged in clinical, teaching, and research work for 39 years, with a wealth of clinical experience in the diagnosis and treatment of critical and difficult cases of respiratory system diseases. Proficient in imaging diagnosis and treatment of chest diseases such as chronic obstructive pulmonary disease, pulmonary infectious diseases, pleural diseases, lung nodules, and lung cancer. Rich clinical experience in the application and operation of bronchoscopy.

Publications:
Published a total of 24 papers and participated in the editing of 5 books and teaching materials.

Honors:
Received awards such as Outstanding Individual of the Year at the Second Affiliated Hospital of Nanjing Medical University, and the Third Prize for Outstanding Contributions in Medical Education and Research at the hospital.

Professional Affiliations:
1. Member of the Asthma Home in Nanjing.
2. Director of the Anti-Tuberculosis Association in Nanjing.
3. Member of the Respiratory Professional Committee and Medical Accident Identification Expert in Nanjing Medical Association.
4. Expert in the Anti-SARS Expert Group in Jiangsu Province, Nanjing City, and Nanjing Medical University.
5. Expert in the Respiratory Professional Committee and Provincial Expert Database of Jiangsu Medical Association.
6. Deputy Leader of the Chronic Obstructive Pulmonary Disease Group in the Respiratory Professional Committee of Jiangsu Medical Association.

Lin Yong
Chief Physician, Professor, PhD

Education: Southeast University School of Medicine, Nanjing Chest Hospital, Department of Respiratory Medicine, Chief Physician

Department: Department of Respiratory Medicine

Specialties: Critical respiratory diseases, pulmonary infections, diagnosis and treatment of difficult respiratory diseases.

Main Experiences:
Chief Physician, Department of Respiratory Medicine, Nanjing Chest Hospital, Southeast University School of Medicine

Treatment Expertise:
Specializing in critical respiratory diseases, pulmonary infections, and diagnosis and treatment of difficult respiratory diseases.

Has extensive clinical experience in the diagnosis and differential diagnosis of pulmonary nodules, with a high reputation in the industry for distinguishing between benign and malignant ground-glass nodules on lung CT scans. Accumulated rich clinical experience, particularly skilled in the diagnosis and treatment of chronic cough, lung cancer, challenging pulmonary infections, sleep apnea (commonly known as snoring), chronic obstructive pulmonary disease, bronchial asthma, pleural effusion, differential diagnosis and treatment of lung masses, as well as the diagnosis and treatment of difficult and critical respiratory diseases.

Academic Positions:
Member of the Critical Care Professional Committee of the Chinese Respiratory Physicians Association

Member of the Respiratory Intensive Care Group of the Chinese Geriatrics Society Respiratory Branch

Vice Chairman of the Respiratory Disease Branch of the Jiangsu Medical Association (7th, 8th, 9th, 10th sessions)

Head of the Respiratory Critical Care Group of the Jiangsu Medical Association Respiratory Branch

Head of the Respiratory Critical Care Group of the Jiangsu Respiratory Physicians Association

Editorial Board Member of the “Chinese Journal of Respiration and Critical Care Medicine”

Editorial Board Member of the Chinese version of “Thorax”

Dr. Liu Jun
 
Title
 
Director of Traditional Chinese Medicine (TCM) Department, Chief Physician, Professor, Academic Successor of National Famous Senior TCM Experts
 
Education
 
Master of Acupuncture, Tuina & Massage, Heilongjiang Academy of Chinese Medical Sciences
 
Department
 
Department of Traditional Chinese Medicine
 
Professional Experience
 
  • 2009–2021: Director & Chief Physician, Department of Traditional Chinese Medicine, Heilongjiang Academy of Chinese Medical Sciences
 
Clinical Specialties
 
Coming from a family with a long tradition of TCM practice, he has a solid command of fundamental TCM theories. Under the guidance of syndrome differentiation and treatment, he specializes in treating diseases of internal medicine, gynecology, pediatrics, andrology, and dermatology using Chinese herbal medicine and acupuncture.
 
  • Cerebrovascular diseases and their sequelae; facial paralysis, insomnia, tremors, epilepsy, various types of postherpetic neuralgia
  • Refractory hypertension, coronary heart disease, arrhythmia; pulmonary nodules, thyroid nodules, breast nodules
  • Cervical and lumbar diseases, scapulohumeral periarthritis, tennis elbow, femoral head necrosis, knee joint effusion, soft tissue injury
  • Osteoarthropathy, rheumatoid arthritis, ankylosing spondylitis, Sjögren’s syndrome, gouty arthritis
  • Hiccup, gastritis, gastric ulcer, gastrointestinal dysfunction; intractable cough, asthma, COVID-19 sequelae
  • Neurogenic bladder, chronic prostatitis, benign prostatic hyperplasia; eczema, urticaria, neurodermatitis
  • Menstrual irregularities, perimenopausal syndrome, polycystic ovary syndrome, infertility; tumors and postoperative conditioning
 
Research Interests
 
Proficient in classical theories of traditional Chinese medicine and the comprehensive application of TCM principles, methods, prescriptions, and medicines.
 
A disciple of Professor Zhang Jin, a leading authority in acupuncture, he masters a variety of acupuncture techniques.
 
He has conducted in-depth research on the clinical application, prevention, and health care value of TCM herbal pastes.
 
He practices a wide range of therapies including oral and external herbal medicine, acupuncture, moxibustion, medicinal bathing, fumigation, dog-day paste, three-nine paste, massage, and tuina.
 
Academic Memberships
 
  • Vice Chairman, Acupuncture Committee of Heilongjiang Province
  • Vice Chairman, Moxibustion Committee of Heilongjiang Acupuncture Association
  • Standing Member, Rheumatology Committee of Heilongjiang Association of Chinese Medicine
  • Vice Chairman, Rheumatology Branch of Heilongjiang Association of Integrated Traditional Chinese and Western Medicine
  • Vice Chairman, Medical Quality Control Center of Suzhou National Hi-Tech District
  • Vice Chairman, Traditional Chinese Medicine Committee of Suzhou National Hi-Tech District Medical Association
 
Research Achievements
 
  • Published more than 30 academic papers in statistical-source core journals including series journals of the Chinese Medical Association
  • Participated in numerous research projects supported by the National Natural Science Foundation of China and Heilongjiang Provincial Natural Science Foundation
  • Received 2 Second Prizes and 1 Third Prize of Heilongjiang Provincial Science and Technology Progress Award
  • Awarded 3 Second Prizes of Heilongjiang Provincial TCM Science and Technology Progress Award
  • Won 1 First Prize and 2 Second Prizes of Heilongjiang Provincial Medical and Health New Technology Application Award

Pan Yucheng
Attending Physician, Doctor of Medicine

Main Experience:
Doctor of Traditional Chinese Medicine (Rheumatology), Nanjing University of Chinese Medicine

Bachelor of Traditional Chinese Medicine, Nanjing University of Chinese Medicine

Department of Psychological Rehabilitation, Private Fu Jen Catholic University

Main Specialties:
Respiratory diseases such as external pathogens and cough;
Digestive system diseases such as epigastric discomfort;
Sleep disorders, menopausal syndrome;
Postpartum rheumatism, postpartum joint pain, and other postpartum diseases;
Various other miscellaneous diseases.

Liu Jun
Director of Traditional Chinese Medicine Department, Chief Physician, Professor, National Famous Old Chinese Medicine Academic Successor

Education: Master’s degree in Acupuncture and Tuina from Heilongjiang University of Chinese Medicine

Department: Traditional Chinese Medicine
Main Experience:
2009-2021 Director of Traditional Chinese Medicine Department, Chief Physician, Heilongjiang University of Chinese Medicine

Expertise:
With a deep family background in traditional Chinese medicine, proficient in the basic theories of Chinese medicine, skilled in using Chinese herbal medicine, acupuncture, and moxibustion under the guidance of syndrome differentiation treatment. Specializes in treating internal medicine, gynecology, pediatrics, andrology, and dermatology diseases.

Cerebrovascular diseases and sequelae; facial paralysis, insomnia, tremors, epilepsy, various post-neuralgia pains;

Difficult-to-treat hypertension, coronary heart disease, arrhythmia; pulmonary nodules, thyroid nodules, breast nodules;

Cervical and lumbar spondylosis, frozen shoulder, tennis elbow, avascular necrosis of the femoral head, knee joint effusion, soft tissue injuries;

Osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, Sjogren’s syndrome, gouty arthritis;

Hiccup, gastritis, gastric ulcer, gastrointestinal dysfunction; difficult-to-treat cough, asthma, post-COVID-19 sequelae;

Neurogenic bladder, chronic prostatitis, benign prostatic hyperplasia; eczema, urticaria, neurodermatitis;

Menstrual disorders, perimenopausal syndrome, polycystic ovary syndrome, infertility; tumor and postoperative care, etc.

Main Research Directions:
Proficient in classical theories of traditional Chinese medicine, integrating theory, diagnosis, treatment, and prescription. Studied under the acupuncture master Zhang Jin, proficient in various acupuncture techniques. Deep research on the clinical treatment and preventive healthcare of Chinese herbal medicine prescriptions, using internal and external Chinese herbal medicine, acupuncture, moxibustion, medicated baths, fumigation, Sanfu plaster, Sannine plaster, massage, and tuina.

Social and Association Positions:
Vice Chairman of the Acupuncture Professional Committee of Heilongjiang Province;

Vice Chairman of the Moxibustion Professional Committee of the Acupuncture Society of Heilongjiang Province;

Executive Committee Member of the Rheumatology Professional Committee of the Chinese Medicine Association of Heilongjiang Province;

Vice Chairman of the Rheumatology Branch of the Integrated Chinese and Western Medicine Association of Heilongjiang Province;

Vice Chairman of the Medical Quality Control Center of Jiangsu High-tech Zone;

Vice Chairman of the Traditional Chinese Medicine Professional Committee of the Medical Association of Suzhou High-tech Zone.

Research Achievements:
Published more than 30 papers in core journals such as the series of medical journals of the Chinese Medical Association. Participated in various research projects such as the National Natural Science Foundation and the Natural Science Foundation of Heilongjiang Province. Received 2 second prizes and 1 third prize of the Scientific Progress Award of Heilongjiang Province; 3 second prizes of the Scientific and Technological Progress Award of Heilongjiang Province; 1 first prize and 2 second prizes of the Medical and Health New Technology Application Award of Heilongjiang Province.

Wang Zhongshan
Chief Physician, Associate Professor

Education: Master’s degree

Department: Traditional Chinese Medicine

Specialties: Proficient in using ancient formulas to treat the following conditions: 1. Traditional Chinese medicine treatment for digestive, respiratory system, and gynecological tumors (including toxic side effects after radiotherapy and chemotherapy) 2. Traditional Chinese medicine treatment for women’s pregnancy, postpartum, and miscellaneous diseases 3. Traditional Chinese medicine treatment for rheumatic and metabolic diseases, such as arthritis, ankylosing spondylitis, lupus, etc. 4. Traditional Chinese medicine treatment for some difficult miscellaneous diseases of the digestive and respiratory systems

Main Experiences:
1. Renowned expert at Nanjing Mingji Hospital’s National Medicine Hall;
2. Associate Professor and Deputy Chief Physician at Nanjing University of Chinese Medicine;

Areas of Expertise:
1. Traditional Chinese medicine treatment for digestive, respiratory system, and gynecological tumors (including toxic side effects after radiotherapy and chemotherapy)
2. Traditional Chinese medicine treatment for women’s pregnancy, postpartum, and miscellaneous diseases
3. Traditional Chinese medicine treatment for rheumatic and metabolic diseases, such as arthritis, ankylosing spondylitis, lupus, etc.
4. Traditional Chinese medicine treatment for some difficult miscellaneous diseases of the digestive and respiratory systems

Memberships:
Member of the Zhongjing Theory Branch of the Chinese Association of Traditional Chinese Medicine

Publications:
Authored 5 professional works; published over 10 articles in national journals

Research:
Led 12 research projects at national, provincial, and university levels, including 1 project from the Ministry of Science and Technology, 4 provincial research projects, and 7 university-level research projects

Honors:
Leader of the Excellent Scientific and Technological Innovation Team at Nanjing University of Chinese Medicine

Please leave your name and contact information, and our medical tourism consultant will contact you within 12 hours. Thank you for your inquiry!

Medical Tourism in China | Suzhou Fenglin International

Please leave your name and contact information, and our medical tourism consultant will contact you within 12 hours. Thank you for your inquiry!

Medical Tourism in China | Suzhou Fenglin International

Please leave your name and contact information, and our medical tourism consultant will contact you within 12 hours. Thank you for your inquiry!

Medical Tourism in China | Suzhou Fenglin International

请审查以下重要信息,包括护照、签证等信息

护照信息
您的护照必须在旅程结束后至少有效六(3)个月,并且入境和出境印章应至少有两(2)页空白签证页。

我们提供简便高效的美国护照和签证处理服务,会以枫林国际旅行社的身份给您发旅游邀请函,有需要可以联系我们,需支付服务费150美金

签证信息
作为游客,您需完全负责确保携带进入中国所需的旅行证件,非免签国家游客进入中国需持旅游签证,必须在出发前直接向中国领事馆申请或通过签证处理服务获得。持有有效10年期多次入境中国签证且持有过期护照且个人信息未变的旅客,出行时必须携带过期护照和新护照。如果被要求提供在中国接待您的旅行社,请注明枫林国际旅行社:代理机构#350484

注意:请勿表示计划前往西藏,否则申请将被拒。所有前往西藏的旅客都需要特别许可,枫林国旅将代为办理。请确保在出发前60天内提供高质量的护照信息页和有效的中国签证复印件以便我们办理入藏手续。

只有当您从南美或非洲黄热病流行区抵达或经过该地时,才需要在抵达前至少10天接种黄热病疫苗。CDC和WHO各自提供了所有受影响国家的最新名单。请务必携带医生提供的国际疫苗接种证明,否则可能会被拒绝入境。如果医生建议不要接种疫苗,他们可以提供必要的相关文件。

有任何不清楚的地方可以向我们咨询,我们乐意为您解答。

—–枫林国际旅行社

Please leave your name and contact information, and our medical tourism consultant will contact you within 12 hours. Thank you for your inquiry!

Selected Value: 1
Selected Value: 0
Selected Value: 0